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Chapter 1 
INTRODUCTION 
Hypertensive disorders occur in approximately 8-10% of all pregnancies (1) They 
remain a major cause of maternal and fetal morbidity and mortality, as well as an 
area marked by substantial controversy concerning cause, pathophysiologic process 
and treatment (2). Dietary sodium intake is one of the many factors that have been 
related to the pathophysiology of hypertensive disorders of pregnancy In the 
Netherlands this resulted in the use of dietary sodium restriction during pregnancy as 
a prophylactic and therapeutic measure in hypertensive disorders However, the 
(patho)physiological impact of a low sodium diet on mother and fetus is largely 
unknown 
Prescription of a low sodium diet in pregnancy 
In the Netherlands the use of a low sodium diet in pregnancy as a prophylaxis and 
treatment of hypertensive disorders was introduced by De Snoo in 1912 (3-5) He 
believed that the custom of salting the food was highly responsible for the occurence 
of eclampsia and partly also for toxemia, causing an excessive retention of sodium 
and water due to a greater affinity for salt of the tissues of pregnant women (5-7) He 
stated "without salt retention, no eclampsia" (6) His data showed that after the 
introduction of a low sodium diet as a routine therapy the incidence of convulsions 
was largely reduced after the third day of admission (4,5) However, this effect could 
alternatively be explained by the introduction of systematic prenatal care (4,5,8) De 
Snoo has never demonstrated a beneficial effect of sodium restriction on the 
prevention of hypertensive disorders of pregnancy Nevertheless, he wrote "It would 
be well if the women were to be forbidden the use of salt in the second half of their 
pregnancy There would then be far fewer cases of serious toxemia, and it would 
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practically put an end to eclampsia" (5,8). In subsequent studies on sodium restriction 
in relation to the incidence and severity of hypertensive disorders of pregnancy 
contradictory results have been reported. Chesley and Annitto (9) studied 237 
potentially pre-eclamptic patients (because they retained excessive extracellular water 
during the 3rd trimester). They reported that the incidence of toxemia was 
considerably lowered in patients who restricted salt and increased water intake 
(7.9%), compared to patients who restricted both salt and water intake (23.5%) and 
patients without dietary measures (22.5%). The fact that the incidence of toxemia was 
not lowered in patients who restricted both salt and water intake was partially 
attributed to a concentration of unfavorable cases in this group. Robinson (10) 
investigated 2019 pregnant women; 1019 were advised to take more salt in their diet 
(to use more salt in cooking, to add extra salt to their food at the table and to eat 
salted bacon, fish, nuts and butter) and 1000 to take less salt (to use as little salt as 
possible in cooking, to refrain from adding salt to their food at the table and to eat 
smoked bacon, unsalted butter and unsalted fish). Unexpectedly, a lower incidence of 
toxemia, edema, perinatal death, antepartum hemorrhage and bleeding during 
pregnancy was observed in those women told to take more salt. Subsequently, 20 
women with early toxemia were treated with extra salt only. The clinical status of all 
of them improved and the larger the dose of salt taken the quicker and more 
complete was the recovery. Therefore Robinson concluded that extra salt in the diet 
seems to be essential for the health of a pregnant woman, her fetus and the placenta. 
Unfortunately, in this study dietary compliance was not checked and only clinical data 
of 4 of the 20 toxemic patients were presented. Zuspan and Bell (11) disagreed with 
Robinson, since the results in their study on variable salt-loading during pregnancy 
indicated that an excessive intake of salt is detrimental to moderately pre-eclamptic 
patients. They stated that their results reconfirm the dictum that the pregnant patient 
does better on a low salt diet, especially the toxemic patient. Mengen and Tacchi (12) 
conducted a trial to determine whether differences in salt ingestion alter the course of 
pre-eclampsia. Pre-eclamptic women were either set on a high salt (6-7 g sodium per 
day) or low salt (0.5-1.0 g sodium per day) diet. They found no difference in the 
clinical course of pre-eclampsia. However, the average urinary sodium excretions were 
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approximately the same in both groups (although not expressed per 24 hour, but per 
liter), suggesting that there was no real difference in sodium intake at all between 
both groups. Bower (13) did not observe any differences in the rate of Caesarean 
section, perinatal mortality, number of days in the hospital, infant birth weight, 
incidence of eclampsia and blood pressure trends between pre-eclamptic women with 
different salt intakes (25, 10 or 2 g of salt daily). Again dietary compliance was not 
checked in this study. 
As a result of these conflicting findings a discussion started on the benefit of dietary 
sodium restriction in pregnancy which continues to this day. In the Netherlands many 
gynaecologists, general practitioners and midwives still continue to advise pregnant 
women to reduce their sodium intake. 
A multicenter trial on the benefit of sodium restriction during pregnancy 
Since there seemed to be no controlled studies that allow firm conclusions about the 
value of dietary sodium restriction during pregnancy, in 1986 a multicenter controlled 
randomized study was initiated in the Netherlands to evaluate the prophylactic effect 
of a low sodium diet during pregnancy on hypertensive disorders. The participating 
centers in this study are Calharina Hospital in Eindhoven, University Hospital 
Nijmegen and the hospital Bosch Medicentrum in 's-Hertogenbosch. At this moment 
the overall analyses of the data of this multicenter project are still in process. 
Before proper recommendations on sodium intake during pregnancy can be made, it 
is important to have a thorough understanding of the (patho)physiological 
consequences of a change in sodium intake for mother and fetus. Only very few 
studies have been conducted on this subject and in order to increase our knowledge, 
each participating hospital also studied different side-effects of a low sodium diet in 
pregnancy. Some results on the additional variables studied in the University Hospital 
Nijmegen have already been reported in the thesis of Steegers (14). Herein he 
describes that a low sodium diet during pregnancy resulted in a significantly lower 
maternal weight gain, stroke volume, cardiac output and intake of energy, 
macronutrients and calcium, a significantly higher systemic vascular resistance and 
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sigruficdntly higher plasma concentrations of renin and plasma renin activity No 
effects of the diet on blood pressure, plasma concentrations of prorenin, renin 
substrate, angiotensin converting enzyme, atrial natriuretic peptide, progesterone and 
aldosterone and on infant birth weight and placental weight were observed He 
concluded that a low sodium diet in pregnancy seems to prevent an increase in 
extracellular fluid volume, blood volume and cardiac output and markedly stimulates 
the renin-angiotensin system which results in vasoconstriction of the peripheral 
arterioles and hence an increase in vascular resistance Blood pressure, being the 
product of cardiac output and peripheral vascular resistance, remains unchanged 
In the hospital Bosch Medicentrum in 's-Hertogenbosch the multicenter study 
protocol was extended in such a way that the following questions were also under 
investigation 
Does a low sodium diet in pregnancy also affect the intake of other nutrients ? 
Engstrom and Tobelmann (15) cite an American study in which the food sources of 
sodium were identified The three food groups that contribute most (approximately 
50%) to the average daily sodium intake include grain products, meat, poultry and 
fish and milk and dairy products However, these food groups also contribute most to 
the daily intake of calcium, iron, magnesium and vitamin B6 Therefore they 
hypothesized that there is a risk of inadvertently reducing the intake of other 
important nutrients when foods with a high sodium content are eliminated from the 
diet During pregnancy the requirements for most nutrients are increased (16) and a 
low sodium diet during this period may cause an inadequate supply of nutrients to 
mother and fetus As already described above, Steegers observed a significantly lower 
intake of energy, macronutnents and calcium in pregnant women on a low sodium 
diet (14) However, no other micronutnent than calcium was investigated in his study 
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Does a low sodium diet in pregnancy affect maternal calcium metabolism and/or 
zinc and magnesium status ? 
In recent literature much attention has been given to the importance of consuming 
adequate amounts of calcium, magnesium and zinc during pregnancy. There are 
indications that deficiencies of one or more of these micronutrients during pregnancy 
may affect either the fetus or the mother or both. 
Several studies suggest a role of calcium in the pathophysiology of hypertensive 
disorders of pregnancy. Epidemiological data have shown an inverse relationship 
between dietary calcium intake and the incidence of hypertensive disorders of 
pregnancy (17). This finding was supported by the results of studies on calcium 
supplementation during pregnancy, in which a fall in blood pressure and a reduced 
incidence of hypertensive disorders was found (18-20). In these studies it was 
suggested that changes in calcium metabolism are hereby involved. Belizán et al 
(20,21) hypothesized that a high dietary calcium intake causes a fall in blood pressure 
due to a reduction in the secretion of parathyroid hormone. The reduced parathyroid 
hormone secretion would then reduce free intracellular ionized calcium 
concentrations in vascular smooth muscle cells, causing a reduced vascular tension 
and subsequently vasodilatation. It has also been suggested that calcium 
supplementation reduces the incidence of preterm delivery (22). 
There are several indications for an association between zinc status and maternal-
fetal morbidity. Low circulating zinc concentrations during pregnancy or at delivery 
have been related to congenital malformations (23,24), prolonged labor (25,26), pre-
and postterm delivery (25,26) and hypertensive disorders (26-30). Meadows et al (31) 
demonstrated that maternal leucocyte zinc depletion is associated with impaired fetal 
growth and Scholl et al (32) found that a very low intake of zinc during pregnancy (^ 
6 mg/d) increases the risk of low birth weight, as well as preterm and very preterm 
delivery. Zinc supplementation during pregnancy resulted in a lower incidence of 
pregnancy-induced hypertension (33), it reduced the overall complication rate during 
pregnancy and delivery (34) and reduced the incidence of intrauterine growth 
retardation in pregnant women at risk of delivering small babies (35). 
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Altura et al (36) observed that withdrawal of extracellular magnesium caused 
vasoconstriction in human isolated umbilical vessels which led to the hypothesis that 
hypomagnesemia during pregnancy might carry a risk of developing hypertensive 
disorders of pregnancy. Adequate magnesium intake or metabolism would prevent 
these vascular events. Magnesium may also play a role in the pathophysiology of 
hypertensive disorders because of its inhibitory effect on coagulation and platelet 
function and also because magnesium increased the release of prostacyclin from the 
vessel wall in vitro (37). Several investigators concluded that magnesium 
supplementation during pregnancy could be beneficial with regard to hypertensive 
disorders (38,39), birth weight (38-41) and frequency of preterm delivery (39-42). 
As mentioned above, a low sodium diet in pregnancy may reduce the intake of 
calcium, zinc and magnesium and thus affect calcium metabolism and zinc and 
magnesium status. It is also possible that a low sodium diet influences calcium 
metabolism and magnesium status by a reduced urinary excretion of calcium and 
magnesium. Direct and positive relationships between the excretion of sodium and 
calcium and sodium and magnesium by the kidneys have been reported previously 
(43-45). In affecting calcium metabolism or zinc and magnesium status a low sodium 
diet may affect pregnancy outcome and even indirectly influence blood pressure. 
Does a low sodium diet in pregnancy have an effect on maternal body composition ? 
When compared to the control group, Steegers (14) observed a reduction in weight 
gain over pregnancy of approximately 6 kg in women on a low sodium diet. He 
suggested that this reduction in weight gain was partly due to a reduction in fat 
accumulation during pregnancy. The physiological fat accumulation during pregnancy 
serves as an energy reservoir for late pregnancy and lactation (46,47). Maternal 
weight gain is related to fetal growth (48). Lower weight gains are associated with an 
increased risk of intrauterine growth retardation and increased perinatal mortality. 
Also in this light a low sodium diet in pregnancy may indirectly affect pregnancy 
outcome. 
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Outline of the thesis 
In the present thesis the results of the study conducted in the hospital Bosch 
Medicentrum are described. In Chapter 2 the effects of a low sodium diet in 
pregnancy on blood pressure and on several indices of calcium metabolism are 
presented. The effect on maternal energy and nutrient intake and the feasibility of a 
low sodium diet during pregnancy are described in Chapter 3 The effects of the diet 
on several parameters of maternal zinc and magnesium status are reported in 
Chapter 4, while in Chapter 5 the effects on maternal body composition and 
pregnancy outcome are presented. Finally the summarizing conclusions are given in 
Chapter 6. 
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Chapter 2 
LOW SODIUM DIET IN PREGNANCY: 
EFFECTS ON BLOOD PRESSURE AND CALCIUM METABOLISM 
Gerneke D van der Maten, Joop M A van Raaij, Leontien Visman, 
Herman P. Oosterbaan, Rinze de Boer, Lidwien J.M. van der Heijden, 
Joseph G.A J Hautvast, Tom K.A.B. Eskes 
Abstract 
This study was carried out to investigate the effects of a low sodium diet in pregnancy 
on blood pressure and calcium metabolism Ninety-four nulliparous women were 
studied longitudinally from early pregnancy until 6 weeks post partum. After baseline 
measurements the participating women were randomly divided into an intervention 
group (n=41), which used a low sodium diet (actual mean urinary sodium excretion 
61 mmol/24h) from week 14 of pregnancy onwards until delivery and a control group 
(n = 53), which continued their ad libitum dietary intake No significant effect of the 
low sodium diet on blood pressure was observed When compared to the control 
group, in the intervention group dietary calcium intake and urinary calcium excretion 
were significantly reduced, without a significant change in circulating total calcium, 
ionized calcium or parathyroid hormone It is suggested that the reductions in dietary 
calcium intake and urinary calcium excretion counterbalance each other 
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Introduction 
Although it is a matter of dispute, obstetricians, general practitioners and midwives 
still continue to prescribe a low sodium diet as a prophylactic or therapeutic measure 
in hypertensive disorders of pregnancy in the Netherlands. However, the impact of 
such a diet on mother and fetus is still largely unknown. 
Besides an effect on volume homeostasis, a low sodium diet in pregnancy may also 
have an effect on maternal calcium metabolism. In affecting calcium metabolism it 
may even adversely influence blood pressure. In recent studies in pregnancy a fall in 
blood pressure and a reduction in the incidence of hypertensive disorders have been 
observed after calcium supplementation and it was postulated that alterations in 
calcium metabolism are hereby involved (1-3). A low sodium diet may influence 
calcium metabolism by a reduction in calcium intake (4) and/or a decrease in urinary 
calcium excretion (5,6). This study was designed to investigate the effects of a low 
sodium diet in pregnancy on blood pressure and on parameters of calcium 
metabolism. 
Subjects and methods 
Study design 
Ninety-four nulliparous women visiting the antenatal clinic of the hospital Bosch 
Medicentrum were studied longitudinally from early pregnancy until 6 weeks post 
partum. Pregnancies were dated using the first day of the last menstrual period. If 
ultrasonography in early pregnancy showed a discrepancy in gestational age of 7 days 
or more, pregnancy length was corrected accordingly (17 out of 94 pregnancies). After 
baseline measurements, at week 13 of pregnancy, the women were randomly assigned 
(by closed envelope system) to an intervention group (I-group), which used a low 
sodium diet from week 14 of pregnancy onwards until delivery, and a control group 
(C-group), which continued their ad libitum dietary intake. Blood pressure and heart 
rate measurements, food consumption studies and blood and urinary analyses were 
performed during pregnancy and post partum according to the scheme given in Figure 
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1. The study protocol was approved by the Ethical Committee of the hospital 
INTERVENTION PERIOD 
r i ' • ι 
13 16 
TT"T" 
20 24 
• ι • • • ι • 
28 32 
weeks of pregnancy 
;AD LIBITUM 
: DIET 
Blood pressure 
Heart rate 
Food consumption 
Study 
Blood analysis 
Urinary analysis 
36 40 1 6 
weeks 
post" parfum 
LOW SODIUM DIET 
INTERVENTION GROUP N = 41) 
AD LIBITUM DIET 
(CONTROL GROUP N = 53] 
AD LIBITUM 
DIET 
FIGURE 1 Scheme of measurements Blood pressure measurement includes systolic, diastolic and mean 
arterial pressure Food consumption study includes energy, sodium and calcium intake 
Blood analysis includes total calcium, ionized calcium, parathyroid hormone (which was only 
measured at week 13, 20, 28 and 36 of pregnancy), hematocrit and albumin Urinary 
analysis includes sodium, calcium and creatinine excretion 
Subjects 
After extensive oral and written information 121 pregnant women consented in 
participation They were all Caucasian nulhparous women with singleton pregnancies 
None of the participating women had a personal history of hypertension or used any 
medication at the entry of the study (with the exception of 2 women in the I-group 
and 2 women in the C-group, who used vitamin-mineral supplements containing 
calcium (22-200 mg/d) and continued this during the rest of pregnancy) During the 
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study no vitamin, mineral or trace element containing supplements were prescribed 
except for ferrous and folic acid tablets for the treatment of anemia. 
Fifty-seven women started in the I-group. In the course of the study 9 women did not 
want to continue the low sodium diet, because they experienced the diet as a too 
difficult assignment, 1 woman developed a hyperemesis, 3 women used ritodnne for 
several weeks (a tocolytic agent, that may result in increased sodium and water 
retention (7)), and 3 women were excluded because of obesity (body mass index > 30; 
it has been suggested that obese people may not report their habitual food intake 
validly (8)). Sixty-four women started in the C-group. Of these 1 woman stopped 
because of family problems, 1 woman switched over to a low sodium diet because she 
developed a hypertensive disorder, 3 women used ritodrine for several weeks and 6 
women were obese. As a result the data of 41 women in the I-group and 53 women in 
the C-group were analysed. Their characteristics are given in Table 1. 
Afterwards, based on the actual urinary sodium excretion during the period of 
intervention, out of these 94 women two subgroups were formed. A low sodium 
excretion group (LSE-group; η = 24) with a maximum urinary sodium excretion during 
the intervention period of 60 mmol/24h and a high sodium excretion group (HSE-
group; π = 29) with a minimum urinary sodium excretion of 140 mmol/24h. Their 
characteristics are also shown in Table 1. All but one woman in the LSE-group 
originated from the I-group and all women in the HSE-group originated from the C-
group. 
Dietary intervention 
The women in the I-group received oral and written dietary instructions from a 
trained dietitian and were carefully guided throughout the whole pregnancy. The aim 
of the dietary instructions was to arrive at a dietary sodium intake of approximately 
20 mmol (± 500 mg) per day. The women in the C-group were instructed to maintain 
their usual eating pattern. 
Blood pressure and heart rate 
Systolic, diastolic and mean arterial blood pressure and heart rate were measured at 
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TABLE 1 Maternal and infant characteristics. 
Number of women 
Age (y)2 
Height (cm)2 
Body weight (kg)2 
Body mass index (kg/m2) 
Pregnancy weight gain (kg) 
Length of gestation (d) 
Number of smokers 
during pregnancy (% (n)) 
Vaginal delivery (% (n)) 
spontaneous 
Birth weight (g) 
Boys/Girls 
Breast feeding (% (n)) 
Intervention 
group 
41 
29 + 5 
167.9 ± 5.6 
64.7 ± 8.4 
22.9 ± 2.1 
10.7 ± 4.1 
279 ± 10 
34(14) 
95 (39) 
76 (31) 
3236 ± 481 
22/19 
49(20) 
Control 
group 
53 
28 + 4 
167.5 + 6.5 
65.8 ± 9.0 
23.5 ± 2.9 
12.2 ± 3.9 
278 ± 10 
21 (11) 
94 (50) 
62 (33) 
3207 ± 459 
27/26 
53(28) 
Low sodium 
excretion 
group 
24 
29 + 5 
167.4 + 5.5 
62.8 ± 8.43 
22.4 + 2.3 
9.5 ± 4.43 
277 + 12 
29 (7)3 
96(23) 
71 (17) 
3188 ± 432 
13/11 
50 (12) 
High sodium 
excretion 
group 
29 
28 + 4 
168.8 + 7.0 
67.8 ± 9.0 
23.8 + 2.9 
12.9 + 3.4 
279 ± 10 
7(2) 
97 (28) 
66 (19) 
3301 ± 469 
16/13 
55 (16) 
plus minus values are means ± SD 
al enliy of sludy (week 13 of pregnancy) 
significantly different from high sodium excretion group (p<005) 
4 
last recorded body weight dunng pregnancy minus body weight at enliy of sludy 
the right arm, after 4 minutes rest, with an automatic microcomputer assisted 
instrument using the oscillometric technique (Dinamap 1846 SX, Critikon Ine, Tampa, 
USA). Blood pressure and heart rate were measured twice in sitting position and 
twice in left lateral recumbent position, each time with an interval of 4 minutes. The 
mean values of blood pressure and heart rate in sitting position and in left lateral 
recumbent position were calculated and used for further analyses. 
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Food consumption 
Food consumption was recorded over 7 consecutive days by the weighed record 
technique (8). The women weighed and recorded each item of food and drink 
immediately before consumption and subsequently the leftovers at the end of the 
meal. Weighing was done on an electronic scale incorporating a zeroing button (Type 
39308, Tefal SA, Rumilly, France; weighing range 0-4000 g, accuracy ± 1 g). The 
amount of salt added during cooking or at the table was not recorded. All food and 
drink items recorded were converted into food codes according to the Dutch food 
encoding system (9) and the average daily energy, sodium and calcium intake was 
calculated using the Dutch computerized food composition table (9). For the present 
study, this food composition table was supplemented with data of sodium restricted 
products. 
Blood sampling and analysis 
Blood samples were taken after an overnight fast. Blood was collected in heparinized 
vacuum tubes for the measurement of ionized calcium, in EDTA vacuum tubes for 
the measurement of hematocrit, in lithium heparin gel vacuum tubes for the 
measurement of total calcium and albumin and in vacuum tubes without additives for 
the measurement of parathyroid hormone. Anaerobic conditions were preserved 
throughout collection and analyses as long as possible. The blood in the plain tubes 
was allowed to clot at room temperature and centrifuged at 2500 g for 10 minutes, 
whereafter the serum was separated. The measurements were done immediately, with 
the exception of parathyroid hormone for which the serum was stored at -20°C until 
assayed. Plasma calcium was measured using orthocresolphtalein complex (EPx, 
Abbott, Chicago, USA) (10). Circulating ionized calcium was measured by a calcium-
specific electrode (Corning 288, Ciba Corning, Halstead, UK). Serum parathyroid 
hormone was determined by a commercially available immunoradiometric assay 
directed to the intact human parathyroid molecule (DPC, Los Angeles, USA). 
Albumin was measured by the bromocresol green-dye binding technique (EPx, 
Abbott, Chicago, USA) (11). The overall coefficients of variation for circulating 
calcium, ionized calcium, parathyroid hormone and albumin were calculated as 1.8%, 
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7.7%, 10.2% and 2.1%, respectively. Hematocrit was obtained electronically using a 
cell counter (NE-8000, Sysmex, Kobe, Japan). 
Urinary sampling and analysb 
Twenty-four hour urine samples were collected in plastic containers of 2.5 litres 
(rinsed with 1 N HCl) for the determination of volume, calcium, sodium and 
creatinine. Urinary calcium was measured by flame atomic absorption 
spectrophotometry (PU 9000, Pye Unicam, Cambridge, UK). Urinary sodium was 
determined by flame photometry (Corning 460, Ciba Corning, Halstead, UK). Urinary 
sodium excretion was not only expressed in mmol/24h, but also per unit of creatinine 
excreted, to avoid possible errors arising as a result of incomplete collection. The 
urinary creatinine was determined by the colorimetrie method of Jaffé (VP, Abbott, 
Chicago, USA) (12). The overall coefficients of variation for urinary calcium, sodium 
and creatinine were 2.1%, 1.6% and 2.0%, respectively. 
Statistics 
Longitudinal data were analysed by analyses of variance for repeated measurements 
designs. If a significant effect of stage of pregnancy or stage post partum occured, 
Tukey's studentized range test was used to compare mean values. At certain stages of 
pregnancy and post partum changes from baseline measurements within groups were 
also tested by paired t-tests. To test differences (in changes from baseline values) 
between two groups two sample t-tests were performed. The Shapiro-Wilk test was 
used to evaluate whether the data were a random sample from a normal distribution. 
Data of some maternal and infant characteristics (smoking, vaginal delivery, infant sex 
and breast feeding) were arranged in contingency tables and tested by Chi-squared 
tests. In all tests, p-values were considered significant at the 5% level. Data analyses 
were carried out using the programme provided by SAS (SAS Institute Ine, Cary, NC, 
USA) (13,14). 
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Results 
Urinary sodium excretion 
Urinary sodium excretion during pregnancy and post partum is shown in Figure 2. 
Before intervention, at week 13 of pregnancy, urinary sodium excretion was 148 ± 62 
mmol/24h in the intervention group (I-group) and 142 ± 54 mmol/24h in the control 
urinary sodium excretion (mmol/24-h) 
I ' ' I ' ' ' I • ' • I ' ' • I ' ' ' ι ' • • ι • · • ι ι 
13 16 20 IK 28 32 36 40 1 6 
weeks 
post partum 
weeks of pregnancy 
FIGURE 2 Urinary sodium excretion during pregnancy and post partum in the intervention group (open 
circles), control group (filled circles), low sodium excretion group (open squares) and high 
sodium excretion group (filled squares). Bars represent the SEM. 
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group (C-group). The difference was not statistically significant. After the start of the 
intervention urinary sodium excretion in the I-group decreased significantly to 50 ± 
34 mmol/24h at week 16 of pregnancy (p< 0.0001). No further significant changes 
were observed during the period of intervention (week 14-40 of pregnancy) and mean 
urinary sodium excretion during this period was 61 ± 30 mmol/24h. After delivery 
urinary sodium excretion increased significantly to 119 ± 55 and 122 ± 58 mmol/24h 
at 1 and 6 weeks post partum in the I-group. These values were no longer 
significantly different from the urinary sodium excretion rates at week 13 of 
pregnancy. No significant changes in urinary sodium excretion were found during 
pregnancy in the C-group. During the period of week 14-40 of pregnancy 
(intervention period for I-group) mean urinary sodium excretion was 142 ± 40 
mmol/24h in the C-group, which was significantly higher than the 61 ± 30 mmol/24h 
in the I-group (p< 0.0001). At 1 and 6 weeks post partum urinary sodium excretion in 
the C-group did not differ significantly from that at week 13 of pregnancy. However, 
at 1 week post partum urinary sodium excretion was significantly lower than at week 
16 (p<0.01) and 20 (p<0.05) of pregnancy and at 6 weeks post partum it still differed 
significantly from week 16 of pregnancy (p<0.01). 
Figure 2 also shows the urinary sodium excretion rates of the low sodium excretion 
group (LSE-group) and the high sodium excretion group (HSE-group). In the LSE-
group mean urinary sodium excretion during intervention was 40 ± 11 mmol/24h, 
which was significantly lower than the 169 ± 29 mmol/24h in the HSE-group 
(p< 0.0001). 
Urinary sodium excretion rates expressed per mmol creatinine excreted (Figure 3) 
paralleled those expressed in mmol/24h. Urinary sodium/creatinine ratios before the 
start of the intervention were comparable in the I- and C-group, with values of 12.2 ± 
3.9 and 12.3 ± 3.6, respectively. During the period of intervention the mean 
sodium/creatinine ratio was 5.8 ± 3.3 in the I-group, which was significantly different 
from the 12.7 ± 2.2 in the C-group (p<0.0001). As expected, mean sodium/creatinine 
ratio during the intervention period in the LSE-group (3.7 ± 1.6) was significantly 
different from that in the HSE-group (13.8 ± 2.1) (p<0.0001). 
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urinary sodium/creatimne ratio 
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FIGURE 3 Urinary sodium/crealinine ratio during pregnancy and post partum in the intervention group 
(open circles), control group (filled circles), low sodium excretion group (open squares) and 
high sodium excretion group (filled squares). Bars represent the SEM. 
Blood pressure and heart rate 
Results on systolic and diastolic blood pressure in sitting position are shown in Figure 
4. During pregnancy the lowest systolic and diastolic blood pressure was found at 
week 20 in all 4 groups studied, with the exception of diastolic blood pressure in the 
LSE-group (nadir at week 16). 
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blood pressure (mmHg) 
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FIGURE 4 Systolic and diastolic blood pressure in sitting position during pregnancy and post partum in 
the intervention group (open circles), control group (filled circles), low sodium excretion 
group (open squares) and high sodium excretion group (filled squares) Bars represent the 
SEM 
Blood pressure and heart rate throughout pregnancy. The changes in blood pressure 
and heart rate over pregnancy (last recorded blood pressure c.q. heart rate during 
pregnancy minus blood pressure c.q. heart rate at week 13 of pregnancy) are 
presented in Table 2 for the I- and C-group and in Table 3 for the LSE- and HSE-
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TABLE 2 Blood pressure and heart rate in pregnancy and post partum in the intervention and control 
group ' 
Intervention (I-) group (n = 41) 
change wk 13 difference 
wk 13 
In sitting position: 
-Systolic blood pressure (mmHg) 114 + 13 
-Diastolic blood pressure (mmHg) 68 + 9 
-Mean arterial pressure (mmHg) 86 ± 10 
-Heart rate (beats/mm) 82 + 10 
In left lateral recumbent position: 
-Systolic blood pressure (mmHg) 99 + 10 
-Diastolic blood pressure (mmHg) 53 ± 7 
-Mean arterial pressure (mmHg) 68 ± 10 
-Heart rale (beats/min) 75 ± 9 
Control (C-) group (n = 53) 
change wk 13 difference 
wk 13 
In sitting position: 
-Systolic blood pressure (mmHg) 118 + 12 
-Diastolic blood pressure (mmHg) 72 + 8 
-Mean arterial pressure (mmHg) 90 + 9 
-Heart rate (beals/min) 85 + 12 
In left lateral recumbent position: 
-Systolic blood pressure (mmHg) 102 + 11 
-Diastolic blood pressure (mmHg) 57 + 7 
-Mean arterial pressure (mmHg) 72 + 10 
-Heart rate (beats/min) 79 + 9 
pre-delivery means last measurement before delivery 
change significantly different from 0 (p<0 05) 
difference significantly different from 0 (p<0 05) 
nre-deliverv 
126 ± 
78 ± 
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87 ± 
107 ± 
62 ± 
78 ± 
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123 
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TABLE 3 Blood pressure and heart rale in pregnancy and post partum in the low sodium excretion and 
high sodium excretion group. 
Low sodium excretion (LSE-) group (n = 24) 
change wk 13 difference 
wk 13 pre-delivery^ 6 wks pp to prc-dclivcrv 6 wks pp-wk 13 
In silling position: 
-Systolic blood pressure (mmHg) 112 ± 11 119 ± 11 111 ± 11 7 ± 1 1 3 -1±10 
76 ± 7 72 ± 8 8 ± 83 4 ± 7* 
94 ± 8 8 8 ± 1 0 8 ± 8 3 3 ± 9 
84 ± 12 78 ± 13 3 + 1 0 -4 ± 13 
-Diastolic blood pressure (mmHg) 68 
-Mean arterial pressure (mmHg) 85 
-Heart rate (beats/min) 81 
In left lateral recumbent position: 
-Systolic blood pressure (mmHg) 98 ± 10 
-Diastolic blood pressure (mmHg) 52 ± 7 
-Mean arterial pressure (mmHg) 67 ± 9 
-Heart rate (beats/min) 74 ± 10 
100 
56 
73 
74 
10 
9 
10 
11 
98 ± 11 
56 ± 7 
71 ± 10 
68 ± 11 
2 ± 8 
4 ± 6 1 
5 ± 7 3 
0 ± 8 
4 ± 8" 
3 ± 9 
High sodium excretion (HSE-) group (n = 29) 
change wk 13 difference 
wk 13 
In sitting position: 
-Systolic blood pressure (mmHg) 120 ± 1 3 
-Diastolic blood pressure (mmHg) 72 + 8 
-Mean arterial pressure (mmHg) 91 ± 9 
-Heart rale (beats/min) 83 ± 8 
In left lateral recumbent position: 
-Systolic blood pressure (mmHg) 105 ± 12 
-Diastolic blood pressure (mmHg) 57 ± 7 
-Mean arterial pressure (mmHg) 73 ± 10 
-Heart rate (beats/min) 76 ± 7 
pre-delivcrv 
129 ± 
80 ± 
100 ± 
86 + 
110 ± 
63 ± 
80 ± 
78 ± 
14 
9 
12 
11 
16 
9 
12 
10 
6 wks 
116 ± 
76 ± 
93 ± 
79 ± 
102 ± 
58 ± 
74 ± 
70 ± 
PP 
14 
7 
10 
9 
11 
8 
9 
7 
to pre-delivcrv 
9 ± 123 
8 ± 103 
10 ± 133 
3 ± 14 
6 ± 133 
6 ± 9 3 
8 ± 131 
1 + 12 
6 wks pp-wk 13 
-4 
4 
2 
-4 
-3 
1 
1 
-6 
± 13 
± 10 
± 11 
± 10 
± 10 
± 9 
+ 9 
± 8 4 
values are means ± SD 
о 
pre-delivery means last measurement before delivery 
^ change significantly different from 0 (p<005) 
difference significantly different from 0 (p<0 05) 
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group. Systolic, diastolic and mean arterial blood pressure increased significantly over 
pregnancy, in both sitting and left lateral recumbent position, in the I- and C-group 
and in the LSE- and HSE-group, with the exception of systolic blood pressure in left 
lateral recumbent position in the LSE-group. No significant differences were found in 
changes in systolic, diastolic and mean arterial blood pressure and heart rate over 
pregnancy between the I- and C-group or between the LSE- and HSE-group. 
Blood pressure and heart rate post partum. The differences in blood pressure 
between week 13 of pregnancy and 6 weeks post partum are also shown in Table 2 
and 3. Based on these differences, no significant differences were found in blood 
pressure and heart rate at 6 weeks post partum, in both positions measured, between 
the I- and C-group or between the LSE- and HSE-group. 
Energy, sodium and calcium intake 
Daily energy, sodium and calcium intake during pregnancy is shown in Table 4. Since 
analyses of variance on the energy, sodium and calcium intake showed no significant 
changes during the period of intervention, mean intake during intervention (week 20, 
28 and 36 of pregnancy) was taken and subsequently the changes in intake between 
intervention period and baseline (week 13 of pregnancy) were calculated. Based on 
these changes, the daily energy, sodium and calcium intake during intervention was 
significantly reduced in the I-group by 1.7 MJ, 2012 mg and 198 mg respectively, when 
compared with the C-group. Corresponding values for the LSE-group when compared 
with the HSE-group were 1.5 MJ, 2195 mg and 162 mg respectively. 
Circulating calcium, ionized calcium, parathyroid hormone, hematocrit, albumin and 
urinary calcium excretion 
Table 5 shows the results on circulating calcium, ionized calcium and parathyroid 
hormone and urinary calcium excretion at week 13 and 36 of pregnancy and their 
changes over this period. 
Plasma calcium decreased significantly during pregnancy and reached its nadir at 
week 32 of pregnancy in all groups studied. The difference in decrease from week 13 
to 36 of pregnancy was neither significant between the I- and C-group nor between 
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TABLE 4 Daily 
Intervention (Ι, η 
Energy (MJ/d) 
Sodium (mg/d) 
Calcium (mg/d) 
energy, sodii 
= 41) versus 
I 
С 
I 
с 
I 
с 
jm and calcium intake 
control group (C, n = 
wk 133 
9 3 ± 1.7 
8.4 ± 1.6 
2955 ± 853 
2830 ± 619 
1041 ± 358 
1036 ± 373 
: during 
53): 
pregnancy. ' 
mean wk 
20.28.36 
8.0 ± 1.5 
8.8 ± 1.5 
798 ± 438 
2671 ± 637 
878 ± 290 
1061 ± 354 
difference 
-1.3 ± 1.64'5 
0.4 ± 1.34 
-2157 ± 97Г1·5 
-145 ± 610 
-163 ± 2814·5 
35 ± 282 
Low (LSE, η = 24) versus high sodium excretion group (HSE, η = 29): 
mean wk 
Energy (MJ/d) 
Sodium (mg/d) 
Calcium (mg/d) 
LSE 
HSE 
LSE 
HSE 
LSE 
HSE 
wk 136 
9.4 ± 1.6 
8.6 ± 1.5 
3035 ± 785 
2979 ± 578 
1121 ± 393 
1082 ± 321 
20.28.36 
8.5 ± 1.3 
9.2 ± 1 6 
740 ± 323 
2826 ± 706 
954 ± 304 
1097 ± 331 
difference 
-0.9 ± 1.54·7 
0.6 ± l . l 4 
-2348 ± 7914 '7 
-153 ± 518 
-147 ± 3427 
15 ± 231 
values are means ± SD 
ρ 
sodium intake calculated without salt added during cooking or at the table 
* η =52 in C-group 
difference significantly different from0(p<005) 
difference significantly different from difference in control group (p<0 01) 
η = 23 in LSE-group 
difference significantly different from difference in high sodium excretion group (p<0 05) 
the LSE- and HSE-group. 
In the I-group ionized calcium decreased significantly from week 13 to 36 of 
pregnancy, while in the C-group no significant changes were observed. The difference 
in change during this period between both groups was not significant. No significant 
changes in ionized calcium during pregnancy were observed in the LSE- and HSE-
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T A B L E 5 Circulating calcium, ioni7cd calcium and parathyroid hormone and urinary calcium excretion 
during pregnancy 
Intervention (I) versus control (C) 
Circulating 
Urinary 
Low (LSE) 
Circulating 
Urinary 
Ca (mmol/1) 
Ca2+ (mmol/1) 
PTH (pmol/l) 
Ca (mmol/24h) 
I 
С 
I 
с 
1 
с 
I 
с 
group: 
η 
40 
53 
24 
28 
40 
53 
41 
51 
wk 13 
2 24 ± 0 10 
2 25 + 009 
1 17 ± 0 06 
1 17 ± 0 07 
0 74 + 0 57 
0 59 ± 0 52 
7 26 ± 3 03 
6 58 + 265 
versus high (HSE) sodium excretion group: 
Ca (mmol/1) 
Ca2+ (mmol/1) 
PTH (pmol/l) 
Ca (mmol/24h) 
LSE 
HSE 
LSE 
HSE 
LSE 
HSE 
LSE 
HSE 
η 
23 
29 
12 
12 
23 
29 
24 
27 
wk 13 
2 25 ± 0 09 
2 25 + 007 
1 15 + 0 06 
1 18 i 0 07 
066 ± 064 
0 64 ± 0 57 
7 05 ± 3 18 
738 + 264 
η 
40 
50 
29 
37 
40 
48 
41 
50 
η 
22 
27 
15 
20 
22 
25 
23 
27 
wk36 
2 16 ± 0 09 
218 ± 0 08 
1 13 + 0 07 
1 14 + 0 06 
1 32 + 0 80 
1 35 ± 0 91 
4 58 + 299 
611 ± 396 
wk 36 
2 16 ± 010 
2 19 ± 0 07 
1 14 + 0 06 
1 16 ± 007 
1 38 + 0 84 
141 ± 0 82 
4 75 + 2 96 
6 76 + 423 
η 
39 
50 
15 
21 
39 
48 
41 
48 
η 
21 
27 
5 
10 
21 
25 
23 
25 
difference 
0 07 ± 0 102 
-0 07 ± 0 082 
-0 04 + 0 072 
0 04 + 0 10 
0 63 + 1 oo2 
I) 74 ± 0 942 
-2 69 ± 3 172 ' 
0 60 + 3 22 
difference 
0 10 + 0 092 
-0 07 ± 0 072 
0 03 + 0 05 
0 04 ± 0 12 
0 78 ± 1 OO2 
0 76 ± 0 902 
-2 56 + 3 692 
0 66 + 3 50 
values are means ± SD 
ρ 
difference significa η ι ly di 
^ difference significantly different from difference in control group (p<0 01) 
ρ 
difference significantly different from 0 (p<0 05) 
group. 
Serum parathyroid hormone increased significantly from week 13 to 36 of pregnancy 
in all groups studied. Both between the I- and C-group, as well as between the LSE-
and HSE-group, the difference in increase was not significant. 
In the I-group urinary calcium excretion decreased significantly from week 13 to 16 of 
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pregnancy No further significant changes were observed until week 32 of pregnancy, 
whereafter another significant decrease was found until week 40 In the C-group no 
significant changes in urinary calcium excretion during pregnancy were observed The 
difference in decrease in urinary calcium excretion from week 13 to 36 of pregnancy 
between both groups was significant (p<0 01) In the LSE-group urinary calcium 
excretion significantly decreased from week 13 to 36 of pregnancy In the HSE-group 
no significant changes were observed during pregnancy The difference in change in 
urinary calcium excretion from week 13 to 36 of pregnancy was not significant 
between the LSE- and HSE-group (p = 0 07). 
Hematocrit and plasma albumin decreased significantly during pregnancy in both the 
I- and C-group and the LSE- and HSE-group, as will be described in detail elsewhere 
(Chapter 4) No significant differences in decrease in hematocrit and plasma albumin 
were observed between the I- and C-group or between the LSE- and HSE-group 
Discussion 
The anthropometric and other characteristics (Table 1) of the women in the 
intervention group (I-group) and control group (C-group) were comparable and 
agreed well with those previously reported in Dutch pregnant women (15,16) Also 
urinary sodium excretion rates at the entry of the study were comparable (148 ± 62 
and 142 ± 54 mmol/24h for the I- and C-group, respectively) and in line with those 
reported in Dutch non-pregnant women (17) Between the low sodium excretion 
group (LSE-group) and the high sodium excretion group (HSE-group) a significant 
difference was found in body weight at the entry of the study, pregnancy weight gain 
and number of smokers during pregnancy In the Netherlands, throughout pregnancy 
women are usually guided by midwives and they often deliver their babies at home 
The participating women in our study were all guided during pregnancy and delivery 
by obstetricians for a variety of reasons (e.g infertility, maternal age, social reasons). 
To our opinion, none of these reasons will have influenced the results on the 
variables studied. 
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Compliance to the diet 
Although the women in the I-group were strictly instructed in a dietary sodium intake 
of approximately 20 mmol daily, their mean urinary sodium excretion during the 
period of intervention was more than three times as high (61 mmol/24h) However, 
these women had to adhere to the low sodium diet within their households for no 
other reason than participation in the study In this light it is remarkable that they 
still managed to reduce their urinary sodium excretion by more than half the amount 
they were used to (148 mmol/24h) 
Effect of a low sodium diet during pregnancy on blood pressure 
The blood pressure values in the present study confirm the previously described blood 
pressure pattern during gestation a decline during the second trimester with an 
increase thereafter up to term (18,19) In other publications no such 'midpregnancy 
dip' was found, although an increase in blood pressure towards term was observed 
(20,21). As expected, blood pressure values in left lateral recumbent position were 
lower than in sitting position (20,22) 
The non-significant differences in changes in systolic and diastolic blood pressure over 
pregnancy between the I- and C-group were only 1 and 0 mmHg in sitting position 
and 2 and 1 mmHg in left lateral recumbent position, indicating that the low sodium 
diet had no effect on the course of blood pressure during pregnancy Since this effect 
could have been obscured by the fact that not every women adhered strictly to the 
diet, the participating women were rearranged according to their actual urinary 
sodium excretion rates during intervention (LSE- and HSE-group) Also between the 
LSE- and HSE-group no significant differences in changes in blood pressure over 
pregnancy were observed This is in line with 3 recent studies in which no effect of 
sodium restriction in pregnancy on blood pressure was observed (4,23,24) However, 
in the study of Brown et al (23) subjects who developed hypertension were excluded 
and in the study of McEniery et al (24) compliance was not controlled The present 
study had a statistical power of 80% to detect a difference in change in diastolic 
blood pressure over pregnancy between the I- and C-group of 6 mmHg It was 
calculated that a reduction in mean diastolic blood pressure from 78 ± 8 ( = diastolic 
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blood pressure observed pre-delivery in the C-group) to 72 ± 8 mmHg in pregnant 
women would reduce the expected incidence of gestational hypertension (diastolic 
blood pressure г 90 mmHg) from 6 7% to 1 2% 
Using the definition of hypertensive disorders of pregnancy by Davey and 
MacGillivray (25), 2 women (4 9%) m the I-group and 3 women (5 7%) in the C-
group developed gestational hypertension and/or proteinuria (NS) However, one 
should bear in mind that one woman who had developed gestational hypertension was 
excluded from the study because she switched over to a low sodium diet. Thus, in fact 
4 women (7 5%) in the C-group developed a hypertensive disorder, which is still not 
significantly different from the I-group 
Calcium metabolism in pregnancy on an ad libitum diet 
The daily calcium intake in the present study (1061 mg) is comparable with the 
previously reported daily calcium intake in Dutch pregnant women (1149 mg) (26) 
Circulating total calcium declined significantly during pregnancy, as has been 
observed by others, probably due to hemodilution and a consequent fall in the 
protein-bound fraction (27) 
No significant change in circulating ionized calcium during pregnancy was observed, 
which is in line with the results of the studies of Pitkin et al (28) and Seki et al (29) 
Other studies have yielded somewhat contradictory results, with increasing and 
decreasing trends, however, all these reported changes are small in extent and 
therefore it has been suggested that any gestational effect on circulating ionized 
calcium is minimal (27) 
The effect of pregnancy on circulating parathyroid hormone is uncertain at present 
Parathyroid hormone has been reported to be increased, normal or even decreased 
during pregnancy (30) These conflicting results may arise, at least partly, from the 
fact that circulating parathyroid hormone exists as a mixture of intact hormone and 
lower-molecular-weight fragments and that the antisera used for parathyroid hormone 
measurement may have a varying specificity for these circulating moieties of hormone 
(31) In the present study, using antisera directed to the intact hormone (presumably 
the principal biologically active circulating form of the hormone (31)), mean serum 
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parathyroid hormone concentrations were below the non-pregnant normal range (1-6 
pmol/1) (at week 13. 20 and 28) with a significant increase at the end of pregnancy 
(week 36) towards normal values. 
Urinary calcium excretion was increased during pregnancy, as has been reported by 
others (32,33), with mean values just below the upper-normal non-pregnant limit (7.5 
mmol/24h). This can be explained by the gestational increase in glomerular filtration 
rate (32), but also, as Gertner et al suggested (33), by seeing pregnancy as a state of 
physiologic absorptive hypercalciuria due to the increased intestinal calcium 
absorption during pregnancy and a relatively high calcium intake. 
Effect of a low sodium diet during pregnancy on calcium metabolism 
The use of a low sodium diet resulted in a significantly reduced dietary calcium 
intake, without an effect on circulating total calcium and ionized calcium. Also, 
unexpectedly, no effect of the diet on circulating parathyroid hormone was found, 
whereas parathyroid hormone is a major factor in calcium homeostasis maintaining 
circulating calcium levels within narrow limits (34). An effect of the diet on 
hematocrit (as an indicator for hemodilution) and/or plasma albumin could have 
influenced these results, but such an effect was not observed in the present study. 
A significant reduction in urinary calcium excretion was found in the pregnant women 
on the low sodium diet. This decrease in urinary calcium excretion could have been 
due to the reduction in calcium intake, but such an effect is mediated by alterations 
in both the filtering load of calcium and the secretion of parathyroid hormone (35) 
and the latter was not found in the present study. The decrease in urinary calcium 
excretion could also have been due to the reduction in urinary sodium excretion, since 
there are indications in non-pregnant subjects that there is a positive direct 
relationship between the excretion of sodium and calcium by the kidneys (5,6). This 
direct effect of the reduction in urinary sodium excretion on urinary calcium excretion 
could have counterbalanced the reduction in dietary calcium intake and explain, at 
least partly, why no significant changes in other indices of calcium metabolism were 
observed. 
When dietary calcium intake is decreased circulating la,25-dihydroxyvitamin D (1,25-
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(OH)2D) concentrations are elevated to promote intestinal calcium transport (35) In 
the present study fecal calcium and circulating l,25-(OH)2D were not measured, but 
parathyroid hormone is the principal stimulant of the enzyme responsible for the 
production of l,25-(OH)2D (34) and, as mentioned above, no significant effect on 
parathyroid hormone was observed in the present study 
Exchangeable calcium in the bones and in many tissues of the body, especially the 
liver and the intestine, provide a buffer system for maintaining constancy of the 
extracellular fluid calcium ion concentration (34) It is also possible that this buffer 
accounted partly for the homeostasis of calcium in the women on the low sodium 
diet 
In the LSE-group also a significant reduction in dietary calcium intake was observed, 
without any differences in circulating calcium, ionized calcium and parathyroid 
hormone, when compared to the HSE-group However, no significant reduction in 
urinary calcium excretion was found Since the magnitude of the reduction in urinary 
calcium excretion in the LSE-group was comparable with the reduction found in the 
I-group, this was probably only due to the smaller number of subjects in the LSE- and 
HSE-group 
Conclusions 
The present study suggests that a commonly prescribed low sodium diet during 
pregnancy will have no effect on the course of blood pressure. Such a low sodium diet 
may reduce the dietary intake and urinary excretion of calcium, but these effects seem 
to counterbalance each other, resulting in an absence of changes in other indices of 
calcium metabolism 
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Chapter 3 
DIETARY CONSEQUENCES OF A LOW SODIUM DIET 
IN PREGNANCY 
Gerneke D van der Maten, Joop M A van Raaij, Leontien Visman, 
Lidwien J M van der Heijden, Rinze de Boer, Herman Ρ Oosterbaan, 
Tom KAB Eskes, Joseph G A J Hautvast 
Abstract 
In 94 nulliparous women the dietary consequences of a low sodium diet in pregnancy 
were studied longitudinally After baseline data collection the women were randomly 
allocated to an intervention group (I-group, η =41) and a control group (C-group, 
n = 53) The women in the I-group used a low sodium diet from week 14 of pregnancy 
onwards until delivery Mean urinary sodium excretion during intervention in the I-
group (61 mmol/24h) was significantly lower than in the C-group (142 mmol/24h) 
(p< 0 0001) In the 1-group the intake of energy, protein, carbohydrates, fat, calcium, 
sodium, zinc, magnesium, iron and cholesterol was significantly reduced during 
intervention, when compared to the C-group Since the intake of zinc and iron in the 
C-group was already far below the recommended dietary allowances for pregnant 
women, it is suggested that a low sodium diet in pregnancy increases the risk of an 
inadequate supply of particularly these important nutrients to both mother and fetus 
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Introduction 
In the Netherlands there is a general believe that sodium restriction is beneficial 
during pregnancy. Particularly in the case of hypertensive disorders, the first 
therapeutic measure usually taken by most obstetricians and midwives is the 
prescription of a low sodium diet. 
Thusfar not much consideration has been given to the possible dietary consequences 
of sodium restriction. Foods contributing sodium to the diet also contain other 
essential nutrients. Consequently sodium restriction might inadvertently reduce the 
intake of other important nutrients (1). During pregnancy the requirements for most 
nutrients are increased (2) and a reduction in sodium intake during this period may 
subsequently cause an inadequate supply of nutrients to the mother and the fetus. 
The objective of this study was to investigate the effect of a low sodium diet in 
pregnancy on maternal energy and nutrient intake. 
Subjects and methods 
Study design 
After baseline food consumption measurement, at week 13 of pregnancy, the 
participating women were randomly divided (by closed envelope system) into an 
intervention group (I-group) and a control group (C-group). The women in the I-
group used a low sodium diet from week 14 of pregnancy onwards until delivery and 
the women in the C-group continued their ad libitum dietary intake. Subsequently, 
food consumption measurements were performed at week 20, 28 and 36 of pregnancy 
and at 6 weeks post partum. In order to check on compliance to the prescribed diet 
urinary sodium excretion was measured at week 13 and 16 of pregnancy, thereafter at 
4 weeks intervals until delivery and at 1 and 6 weeks post partum. Permission for the 
study was obtained from the Ethical Committee of the hospital. 
Subjects 
The participants all attended the antenatal clinic of the hospital Bosch Medicentrum. 
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They were Caucasian nulliparous women with singleton pregnancies, using no 
medication at the entry of the study, and without a personal history of hypertension. 
Ninety-four women completed the study; 41 in the I-group and 53 in the C-group. 
Their characteristics are given in Table 1. 
Dietary intervention 
Throughout pregnancy women in the I-group received dietary instructions from and 
guidance by a trained dietitian. The dietary instructions were based on a dietary 
sodium intake of approximately 20 mmol (± 500 mg) per day. The women received a 
brochure listing the products that were allowed or forbidden, a brochure with recipes 
and a list with the sodium content of several products. Practical advice was given 
regarding shopping locations and commercial products available. The women in the 
C-group were instructed to maintain their usual eating pattern. To the women in both 
groups no instructions were given by the dietitian regarding the adequacy of their 
diet, nor did they receive any dietary advice from their obstetricians. 
Food consumption 
Food consumption was measured over 7 consecutive days by the weighed record 
technique (3). The women weighed and recorded each item of food and drink 
immediately before consumption and all plate waste, edible and inedible, at the end 
of the meal. Weighing was done on an electronic kitchen scale, that allowed zeroing-
out of a series of foods weighed on the same plate (Type 39308, Tefal SA, Rumilly, 
France; weighing range 0-4000 g, accuracy ± 1 g). Recipes had to be written down 
accurately and the individual portion had to be weighed. The women were instructed 
to describe all the recorded products in detail (e.g. fresh or frozen, raw or cooked, 
brand names). If weighing was not possible the women recorded the consumed food 
and drink items in household measures or in number eaten. The amount of salt 
added during cooking or at the table and the daily intake of medicines were not 
recorded. At the end of each study period the dietitian reviewed the records with the 
women for accuracy and completeness. After the conversion of the recorded food and 
drink items into food codes according to the Dutch food encoding system (4), the 
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TABLE 1 Maternal and infanl characteristics. 
Intervention Control 
group group 
Number of women 
Age (y)2 
Height (cm)2 
Body weight (kg)" 
Body mass index (kg/m2) 
Pregnancy weight gain (kg) 
Length of gestation (d) 
Number of smokers during pregnancy (% 
Vaginal delivery (% (n)) 
spontaneous 
Birth weight (g) 
Boys/Girls 
Breast feeding (% (n)) 
(n)) 
41 
29 ± 5 
167.9 ± 5.6 
64.7 ± 8.4 
22.9 ± 2.1 
10.7 ± 4.1 
279 ± 10 
34(14) 
95 (39) 
76 (31) 
3236 ± 481 
22/19 
49(20) 
53 
28 ± 4 
167.5 ± 6.5 
65.8 ± 9.0 
23.5 ± 2.9 
12.2 ± 3 9 
278 ± 10 
21 (11) 
94 (50) 
62 (33) 
3207 ± 459 
27/26 
53(28) 
plus minus values are means ± SD 
al entry of study (week 13 of pregnancy) 
last recorded body weight during pregnancy minus body weight at entry of study 
average daily intake of energy and nutrients was calculated using the Dutch 
computerized food composition table (4). For ferro-fortified products the codes of the 
identical products without the extra iron were used. Ferro-fortified products contain 
excessive amounts of iron and were only used by a few women in the second half of 
their pregnancy. Therefore including the extra iron would complicate the 
interpretation of the iron intake at a group level. Additional data on sodium 
restricted foods and on zinc and magnesium values of foods were added to the food 
composition table. Values were based on different literature sources. When no data 
on zinc and/or magnesium contents were available, values were used from similar 
foods, thus avoiding systematic underestimation of zinc and magnesium intake due to 
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missing data. To study a possible change in the intake of certain food groups, food 
and drink items were classified into 11 different food groups. 
Urine sampling and analysis 
Twenty-four hour urine samples were collected in plastic containers for the 
determination of volume and sodium. Urinary sodium was measured by flame 
photometry (Corning 460, Ciba Corning, Halstead, UK). 
Statistics 
Data analyses were performed on the SAS statistical package (SAS Institute Ine, 
Cary, NC, USA) (5,6). Longitudinal data were analysed by repeated-measures 
analyses of variance, followed by Tukey's studentized range tests in case of significant 
changes. Changes from baseline values during the period of intervention or at 6 
weeks post partum within groups were also tested by paired t-tests. Two sample t-tests 
were performed to test differences (in changes from baseline) between two groups. 
Data of some maternal and infant characteristics (smoking, vaginal delivery, sex of 
offspring and breast feeding) were tested by Chi-squared tests. P-values less then 0.05 
were considered significant. 
Results 
Urinary sodium excretion 
Before the start of the intervention (week 13 of pregnancy) no significant difference 
in urinary sodium excretion was observed between the intervention group (I-group, 
148 ± 62 mmol/24h) and the control group (C-group, 142 ± 54 mmol/24h). 
Throughout the period of intervention (week 14-40 of pregnancy) no significant 
changes in urinary sodium excretion were found. Mean urinary sodium excretion 
during this period was 61 ± 30 mmol/24h in the I-group, which was significantly 
lower than the 142 ± 40 mmol/24h in the C-group (p<0.0001). Post partum values of 
urinary sodium excretion were not different from those at week 13 of pregnancy. 
More details on the results on urinary sodium excretion are reported elsewhere 
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(Chapter 2). 
Energy and nutrient intake during pregnancy 
Daily energy and nutrient intake during pregnancy is shown in Table 2 and 3. 
Analyses of variance on energy and nutrient intake did not show significant changes 
during the period of intervention within the I- and C-group. Therefore mean intake 
over this period (week 20, 28 and 36 of pregnancy) was taken and subsequently the 
changes in intake between intervention period and baseline (week 13 of pregnancy) 
were calculated (see Table 2 and 3). Within the I-group a significantly lower intake of 
energy, protein, carbohydrates, fat, calcium, sodium, zinc, magnesium, iron and 
cholesterol was observed during the period of intervention, when compared to 
baseline. Paired testing in the C-group showed that the intake of energy, 
carbohydrates and alcohol during this period was significantly increased. Based on the 
changes in the I- and C-group, the daily intake of energy, protein, carbohydrates, fat, 
calcium, sodium, zinc, magnesium, iron and cholesterol was significantly reduced 
during the period of intervention in the I-group, when compared to the C-group. In 
addition, during the intervention period in the I-group the percentage of energy from 
fat was significantly reduced, followed by a significant compensatory increase in the 
percentage of energy from carbohydrates, when compared to the C-group. 
Energy and nutrient intake post partum 
In Table 4 and 5 daily energy and nutrient intake at week 13 of pregnancy and at 6 
weeks post partum are given separately for lactating and non-lactating women. In 
addition, the differences in energy and nutrient intake between these two periods are 
shown. Based on these differences in the I- and C-group, the intake of energy and 
nutrients at 6 weeks post partum in the I-group was no longer significantly different 
from the C-group, for both lactating and non-lactating women. The difference in 
energy intake between the I- and C-group observed during baseline measurement (at 
week 13 of pregnancy; 0.6 and 1.2 MJ/d for lactating and non-lactating women, 
respectively) was again observed at 6 weeks post partum (0.8 MJ/d for both lactating 
and non-lactating women). 
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TABLE 2 Daily energy and macronutricnt intake during pregnancy intervention group (Ι, π = 41) versus 
control group (C, η = 53) 
Energy (MJ/d) (9 3MJ/d] 
Protein (g/d) [70 g/d] 
Protein (energy %) 
Carbohydrates (g/d) 
Carbohydrates (energy %) [55 %] 
Fat (g/d) 
Fat (energy %) [30 35 %] 
Alcohol (g/d) 
Alcohol (energy %) 
1 
с 
I 
с 
1 
с 
1 
с 
I 
с 
I 
с 
I 
с 
1 
с 
I 
с 
wk 131 
9 3 
84 
77 
72 
14 
15 
255 
239 
47 
48 
99 
86 
39 
38 
07 
0 1 
02 
0 0 
± 17 
± 16 
± 18 
+ 17 
+ 2 
± 3 
± 47 
± 53 
± 5 
± 6 
± 26 
± 21 
± 5 
± 5 
± 18 
± 0 3 
± 0 7 
± 01 
INTERVENTION 
PERIOD 
mean ' wk 
20.28.36 
80 
88 
65 
73 
14 
14 
235 
250 
50 
48 
78 
90 
36 
38 
11 
0 3 
04 
01 
+ 
± 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
-*-
+ 
+ 
15 
1 5 
10 
15 
2 
2 
57 
52 
5 
5 
17 
19 
4 
4 
22 
08 
08 
02 
difference 
mean 
13 
0 4 
12 
1 
0 
0 
20 
И 
3 
0 
21 
5 
3 
0 
0 4 
0 3 
0 2 
0 1 
wk 13 
± 1 6 4 5 
* 1 3 4 
+ 16 4 5 
± 13 
± 2 
+ 2 
± 4 6 4 · 5 
+ 394 
* 5 4 5 
+ 5 
± 2 2 4 5 
± 19 
± 54·3 
± 4 
± 17 
± 0 9 4 
± 0 6 
± 0 2 4 
values arc means ± SD 
between [J Dutch recommended dietary allowances for pregnant women (1989) are presented 
** η = 52 at week 13 of pregnancy in the С group 
difference between week 13 and mean week 20 28 and 36 of pregnancy significantly different from 0 (p<0 05) 
difference between week 13 and mean week 20 28 and 36 of pregnancy significantly different from difference 
in control group (p<0 01) 
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TABLE 3 Daily micronutrient, cholesterol and dietary fibre intake during pregnancy: intervention group 
(Ι, η = 41) versus control group (C, η = 53) 1 2 3 
Calcium (mg/d) [800-1000 mg/d] 
Sodium (mg/d) 
Potassium (mg/d) 
Zinc (mg/d) [12-15 mg/d]7 
Magnesium (mg/d) [300-350 
Iron (mg/d) [11-19 mg/d]8 
Cholesterol (mg/d) 
Dietary fibre (g/d) 
mg/d| 
I 
С 
1 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
wk 134 
1041 ± 358 
1036 ± 373 
2955 ± 853 
2830 ± 619 
3577 ±713 
3207 ± 842 
10 3 ± 2.4 
9.7 ± 2.2 
311 ± 72 
278 ± 70 
12.0 ± 2.8 
10 8 ± 2.6 
303 ± 82 
269 ± 71 
25 ± 7 
21 ± 6 
INTERVENTION 
PERIOD 
mean wk 
20,28.36 
878 
1061 
798 
2671 
3729 
3296 
8.2 
9.7 
283 
290 
10 6 
10.9 
236 
260 
24 
22 
± 290 
± 354 
± 438 
± 637 
± 701 
± 813 
± 1.5 
± 2.3 
± 61 
± 69 
± 2 1 
± 2.8 
± 58 
± 56 
± 6 
± 6 
difference 
mean-wk 13 
-163 ± 281 s ' 6 
35 ± 282 
-2157 ± 9775·6 
-145 ± 610 
152 ± 618 
101 ± 562 
-2.1 ± 1.95·6 
0.0 ± 1.8 
-28 ± 475 '6 
12 ± 52 
-1.4 ± 2.05·6 
0 1 ± 2 2 
-68 ± 875·6 
-10 ± 60 
-1 ± 5 
1 i 5 
values are means ; SI) 
between [] Dutch recommended dietary allowances for pregnant women (1989) are presented 
3
 salt added during cooking or at the table, the daily intake of medicines and the extra iron in fcrro-fortified 
products arc not included 
η =52 at week 13 of pregnancy in the C-group 
difference between week 13 and mean week 20, 28 and 36 of pregnancy significantly different from 0 (p<0 001) 
difference between week 13 and mean week 20, 28 and 36 of pregnancy significantly different from difference in 
control group (p<0 01). 
1st trimester 12 mg/d, 2nd and 3rd trimester 15 mg/d 
û 
1st trimester 11 mg/d, 2nd trimester 15 mg/d and 3rd trimester 19 mg/d 
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TABLE 4 Daily energy and macronulncnt intake before (wk 13 of pregnancy) and after (6 wks post 
partum) intervention in lactatmg and non-laclaling women: intervention (1) versus control (C) 
group.1·2 
Energy (MJ/d) 
Protein (g/d) 
-(energy %) 
Carbohydrates (g/d^ 
-(energy %) 
Fat (g/d) 
-(energy %) 
Alcohol (g/d) 
-(energy %) 
1 
С 
I 
с 
I 
с 
M 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
pregnancy 
wk 13 
9.5 
8.9 
78 
78 
14 
15 
261 
252 
47 
48 
100 
90 
39 
37 
0.9 
0.2 
0.3 
0.1 
± 1.7 
± 1.4 
± 17 
± 14 
± 2 
± 2 
± 42 
± 44 
± 4 
± 5 
± 26 
± 21 
± 5 
± 4 
± 2.2 
± 0.4 
± 0.9 
± 0.1 
Lactating women 
post partum 
6 wks 
9.2 
8.4 
81 
78 
15 
16 
244 
230 
45 
46 
98 
85 
39 
37 
3.9 
2.9 
1.1 
1.0 
± 1.9 
± 1.4 
± 20 
± 15 
± 3 
± 2 
± 60 
± 46 
± 4 
± 5 
± 23 
± 19 
± 4 
± 4 
± 4.2 
± 4.2 
± 1.0 
± 1.5 
difference 
6 wks DD-wk 13 
-0.2 
-0.5 
3 
0 
1 
1 
-17 
-22 
-2 
-2 
-3 
-5 
0 
0 
3.0 
2.7 
0.8 
1.0 
± 2.1 
± 1.8 
± 21 
± 15 
± 3 
± 2 3 
± 58 
± 5 1 3 
± 4 3 
± 5 
± 26 
± 22 
± 5 
± 4 
± 4.63 
± 4.13 
± 1 . 2 3 
± 1.43 
Non-lactating women 
pregnancy 
wk 13 
9.1 
7.9 
76 
66 
14 
14 
250 
224 
46 
48 
97 
81 
39 
38 
0.5 
0.0 
0.2 
0.0 
± 1.8 
± 1.6 
± 20 
± 17 
± 2 
± 3 
± 51 
± 60 
± 6 
± 7 
± 27 
± 21 
± 6 
± 7 
± 1.4 
± 0.1 
± 0.5 
± 0.0 
post partum 
6 wks 6 
7.5 ± 
6.7 ± 
59 ± 
58 ± 
14 ± 
15 ± 
192 + 
177 ± 
44 ± 
44 + 
83 ± 
72 ± 
41 ± 
40 ± 
5.5 ± 
3.4 ± 
1.9 ± 
1.3 ± 
1.8 
17 
12 
12 
2 
3 
45 
57 
5 
7 
25 
20 
5 
6 
13.8 
6.6 
5.1 
2.5 
difference 
wks pp-wk 13 
-1.7 
-1.0 
-16 
-8 
0 
1 
-63 
-42 
-4 
-4 
-13 
-7 
2 
2 
5.0 
3.4 
1.7 
13 
± 2.53 
± 1.93 
± 21 3 
± 163 
± 3 
± 3 
± 623 
± 5 2 1 
± 6 3 
± 6 3 
± 37 
± 26 
± 6 
± 6 
± 12.5 
± 6 . 6 3 
± 4.8 
± 2 . 5 3 
values are means ± SD 
о 
Lactating women in intervention group η = 20 
Lactaling women in control group η = 28 
Non-lactating women in intervention group η = 21 at week 13, η = 20 at 6 weeks posi partum 
Non-lactating women in control group n = 24 at week 11, n = 22 at 6 weeks post partum 
3
 difference between week 13 of pregnancy and 6 weeks post partum significantly différent from 0 (p<005) 
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TABLE 5 Daily micronutrient, cholesterol and dietary fibre intake before (wk 13 of pregnancy) and 
after (6 wks post partum) intervention in lactating and non-lactating women: intervention (I) 
versus control (C) group.^2,3 
Calcium (mg/d) 
Sodium (mg/d) 
Potassium (mg/d) 
Zinc (mg/d) 
Magnesium (mg/d) 
Iron (mg/d) 
Cholesterol (mg/d) 
Dietary fibre (g/d) 
I 
pregnancy 
wk 13 
1109 
С 1151 
I 3221 
С 2999 
I 3592 
С 3399 
I 
С 
1 
с 
I 
с 
I 
с 
I 
с 
10.4 
10.4 
313 
301 
12.6 
11.] 
306 
277 
25 
23 
± 412 
± 349 
± 850 
± 542 
Lactating women 
post partum difference 
6 wks 6 wks pp-wk 13 
1223 
1164 
2640 
2484 
± 678 3514 
± 828 
± 2.3 
± 2.0 
± 64 
± 60 
± 2.6 
± 2.4 
± 96 
± 72 
± 5 
± 6 
3397 
10.7 
10.2 
327 
305 
11.5 
10.4 
277 
244 
24 
21 
± 504 
± 366 
± 562 
± 575 
± 720 
± 805 
± 2.8 
± 2.6 
± 85 
± 68 
± 2.7 
± 3.2 
± 81 
± 71 
± 6 
± 6 
114 
13 
-580 
-514 
-78 
-2 
0.3 
-0.2 
14 
3 
-1.1 
-0.7 
-29 
-32 
-1 
-2 
± 467 
± 388 
± 999" 
± 645" 
± 671 
± 623 
± 3.0 
± 2.0 
± 76 
± 60 
± 3.2 
± 2.3 
± 119 
± 88 
± 5 
± 4 " 
Non-lactating women 
pregnancy 
wk 13 
977 
902 
2703 
2634 
3563 
2984 
10.2 
8.9 
309 
252 
11.5 
10.5 
301 
260 
25 
20 
± 294 
± 362 
± 794 
± 656 
post partum difference 
6 wks 6 wks pp-wk 13 
737 
681 
2130 
2258 
± 762 2687 
± 819 
± 2.6 
± 2.2 
± 81 
i 73 
± 3.0 
± 2.9 
± 69 
± 69 
± 8 
± 6 
2443 
7.8 
7.7 
242 
221 
8.8 
9.1 
240 
213 
17 
15 
± 250 
± 221 
± 629 
± 620 
± 669 
± 555 
± 1.8 
± 1.9 
± 60 
± 52 
± 2.4 
± 2.3 
± 67 
± 76 
± 6 
± 4 
-265 
-223 
-598 
-370 
-876 
-550 
-2.4 
-1.2 
-69 
-29 
-2.6 
-1.5 
-58 
-50 
-7 
-5 
± 236" 
± 306" 
± 898" 
± 861 
± 877" 
± 75l" 
± 2.8" 
± 2 . 1 " 
± 7 3 " 
± 60" 
± 3 . 5 " 
± 2.6" 
± 1044 
± 91" 
± 7" 
± 5 " 
values are means ± SD 
Lactating women in intervention group η = 20. 
Lactating women in control group η = 28 
Non-lactating women in intervention group η = 21 at week 13, η = 20 at 6 weeks post partum 
Non-lactating women in control group η = 24 at week 13, η = 22 at 6 weeks post partum 
salt added during cookjng or at the table, the daily intake of medicines and the extra iron in 
fcrro-fortified products are not included. 
difference between week 13 of pregnancy and 6 weeks post partum significantly different from 0 (p<005) 
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Intake of food groups during pregnancy 
Daily intake of food groups at baseline (week 13 of pregnancy) and during the period 
of intervention (mean week 20, 28 and 36 of pregnancy) and the changes in intake of 
food groups between the intervention period and baseline are shown in Table 6. 
Within the I-group a significantly lower intake of grain products, milk and dairy 
products, fats, oils and savoury sauces and soups, nuts and mixed dishes and a 
significantly higher intake of vegetables and fruit was observed during the period of 
intervention, when compared to baseline. Within the C-group a significantly higher 
intake of pastries and sweets and of beverages was found during this period, when 
compared to baseline values. Based on the changes in the I- and C-group, the intake 
of grain products, milk and dairy products, fats, oils and savoury sauces and pastries 
and sweets was significantly reduced during intervention in the I-group, when 
compared to the C-group. However, the intake of fruit was significantly increased 
during this period in the I-group, when compared to the C-group. 
Intake of food groups post partum 
In Table 7 the differences in daily intake of food groups between 6 weeks post 
partum and week 13 of pregnancy are given separately for the lactating and non-
lactating women. The lactating women from the I-group only showed a significantly 
lower intake of fruit at 6 weeks post partum, when compared to week 13 of 
pregnancy. Comparing the same periods, the non-lactating women from the I-group 
showed a significantly lower intake of all food groups, except for meats, poultry and 
fish, soups, nuts, and mixed dishes, beverages and rest. In the lactating women from 
the C-group a significantly lower intake of fruit and fats, oils and savoury sauces was 
observed at 6 weeks post partum, when compared to week 13 of pregnancy, while in 
the non-lactating women from this group a significantly lower intake of milk and dairy 
products and fruit and a significantly higher intake of beverages was found. Based on 
the differences in intake of food groups between 6 weeks post partum and week 13 of 
pregnancy, no significant differences were observed between the I- and C-group in 
intake of food groups at 6 weeks post partum in the lactating women. In the non-
lactating women, however, a significantly lower intake of grain products and 
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TABLEÓ Daily intake of food groups during pregnancy (g/d): intervention (I, n = 41) versus control 
group (C, n = 53).' 
Grain products 
Milk and dairy products 
Meats, poultry, fish 
Vegetables 
Potatoes and pulses 
Fruit 
Fais, oils, savoury sauces 
Pastries and sweets 
Soups, nuts, mixed dishes 
Beverages 
Rest 
I 
С 
1 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
wk 132 
167 
152 
419 
470 
142 
122 
165 
142 
177 
155 
363 
338 
43 
38 
88 
76 
199 
225 
974 
917 
5 
3 
± 57 
± 46 
± 223 
± 224 
± 55 
± 44 
± 55 
± 57 
± 54 
± 59 
± 136 
± 143 
± 17 
± 20 
± 35 
+ 44 
± 111 
± 110 
± 299 
± 459 
± 9 
± 2 
INTERVENTION 
PERIOD 
mean wk 
20.28,36 
131 
158 
355 
498 
134 
124 
188 
146 
171 
155 
414 
313 
35 
38 
82 
85 
129 
197 
1025 
1018 
17 
3 
+ 
+ 
+ 
+ 
-t-
+ 
+ 
± 
+ 
+ 
-t-
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
-*-
+ 
+ 
35 
44 
149 
212 
33 
32 
56 
49 
49 
49 
162 
136 
14 
15 
38 
34 
126 
89 
201 
475 
30 
2 
difference 
mcan-wk 13 
-36 ± 
7 ± 
-64 ± 
32 ± 
-8 ± 
1 ± 
23 ± 
4 ± 
-7 ± 
-1 ± 
50 ± 
-19 ± 
-7 ± 
0 ± 
-6 ± 
11 ± 
-70 ± 
-27 ± 
51 ± 
103 ± 
12 ± 
0 ± 
5 13.4 
40 
1593·4 
198 
45 
35 
51 3 
49 
43 
53 
1233·4 
151 
1 5 3 , 4 
13 
434 
373 
1483 
113 
284 
2443 
31 
2 
1 values are means ± SD 
η =52 at week 13 of pregnancy in C-group 
-a 
difference between week 13 and mean week 20, 28 and 36 of pregnancy significantly different from 0 (p<0 05) 
4 
difference between week 13 and mean week 20, 28 and 36 of pregnancy significantly different from difference 
in control group (p<0 05) 
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TABLE 7 Daily intake of food groups (g/d) before (wk 13 of pregnancy) and after (6 wks post partum) 
intervention in lactating and non-lactating women· intervention (I) versus control (C) 
group.1'2 
Grain products 
Milk and dairy 
products 
Meats, poultry, fish 
Vegetables 
Potatoes and pulses 
Fruit 
Fats, oils, 
savoury sauces 
Pastries and sweets 
Soups, nuts, 
mixed dishes 
Beverages 
Rest 
I 
С 
I 
С 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
I 
с 
1 
с 
I 
с 
Lactating women 
pregnancy | 
wk 13 
171 
167 
434 
513 
132 
127 
164 
146 
172 
153 
368 
356 
45 
41 
88 
83 
232 
224 
1051 
880 
6 
3 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
± 
+ 
+ 
+ 
+ 
± 
± 
+ 
44 
44 
261 
198 
49 
46 
46 
59 
57 
63 
128 
142 
18 
22 
36 
48 
124 
125 
342 
483 
12 
2 
post partum 
6 wks ι 
171 
149 
570 
575 
124 
121 
157 
146 
167 
154 
219 
285 
37 
32 
90 
73 
203 
194 
1127 
995 
15 
2 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
± 
± 
+ 
± 
64 
46 
305 
247 
34 
40 
54 
53 
57 
47 
111 
187 
16 
14 
41 
29 
151 
118 
331 
553 
31 
2 
difference 
5 wks DD-wk 13 
-1 
-18 
136 
62 
-8 
-6 
-7 
-1 
-6 
1 
-151 
-70 
-7 
-9 
3 
-8 
-29 
-31 
77 
115 
17 
0 
± 68 
± 51 
± 332 
± 279 
± 48 
± 50 
± 47 
± 56 
± 56 
± 56 
± 1663 
± 1633 
± 23 
± 193 
± 42 
± 54 
± 224 
± 115 
± 375 
± 569 
± 36 
± 2 
1 Чоп-lactaling women 
pregnancy 
wk 13 
162 
133 
405 
420 
152 
115 
167 
137 
183 
158 
358 
316 
41 
34 
89 
67 
168 
225 
901 
960 
4 
3 
± 
± 
± 
± 
± 
± 
+ 
± 
± 
± 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
68 
42 
186 
247 
59 
42 
64 
56 
53 
56 
146 
143 
16 
16 
35 
38 
89 
92 
238 
435 
4 
2 
post partum 
6 wks ι 
125 
129 
313 
246 
122 
119 
114 
125 
146 
139 
185 
172 
32 
28 
68 
56 
188 
179 
921 
1156 
18 
3 
± 
± 
± 
± 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
43 
61 
162 
148 
31 
35 
41 
41 
52 
54 
93 
120 
15 
14 
29 
27 
115 
99 
419 
567 
3i 
2 
difference 
5 wks pp-wk 13 
-40 
-2 
-105 
-157 
-23 
2 
-51 
-17 
-32 
-21 
-169 
-146 
-8 
-5 
-23 
-8 
15 
-50 
2 
183 
16 
0 
± 563·4 
± 54 
± 1633 
± 2233 
± 57 
± 38 
± 403'4 
± 53 
± 5 9 3 
± 73 
± 1173 
± 1743 
ί 153 
± 15 
± 4 5 3 
± 37 
± 127 
± 127 
± 383 
± 2973 
± 32 
± 3 
values arc means ± SD 
Lactating women in intervention group n = 20 Lactating women in control group n = 28 
Non-lactaling women in intervention group n = 21 at week 13, n = 20 at 6 weeks post partum 
Non-lactating women in control group n=24 at week 13, n = 22 at 6 weeks post partum 
° difference between week 13 of pregnancy and 6 weeks post partum significantly different from 0 (p<0 05) 
difference between week 13 of pregnancy and 6 weeks post partum significantly different from difference 
in control group (p<0 05) 
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vegetables was found in the I-group, when compared to the C-group 
Discussion 
Between the intervention group (I-group) and control group (C-group) no significant 
differences were observed with respect to the anthropometric and other 
characteristics of the women (Table 1) These characteristics are comparable with 
data reported earlier on Dutch pregnant women (7,8) 
Choice of food groups 
Control group During pregnancy no significant changes in the use of certain food 
groups were observed, except for a higher intake of pastries and sweets and beverages 
during the second half of pregnancy After delivery, a significantly lower intake of 
fruit in both the lactating and non-lactating women and also a significantly lower 
intake of milk and dairy products in the non-lactating women was found This may 
indicate that, compared to pre-pregnancy intake, during pregnancy women increase 
their consumption of milk and dairy products and fruit, which has been reported 
previously in Dutch pregnant women (9) The fact that in the lactating women the 
intake of milk and dairy products was not reduced after delivery was probably due to 
the general recommendation to continue the pre-delivery advised higher intake of this 
food group when breast feeding 
Intervention group The reduction in sodium intake during pregnancy resulted in a 
significantly lower intake of grain products, milk and dairy products, fats, oils and 
savoury sauces and pastries and sweets The intake of fruit was significantly increased, 
probably because fruit contains very little or no sodium and could serve as a 
substitution for high sodium containing snacks The reduced intake of some food 
groups during pregnancy (intervention period) was continued in the non-lactating 
women after delivery, despite the fact that during this period the low sodium diet was 
no longer prescribed This was not the case in the lactating women, probably because 
in general it is stressed that a well-balanced diet is important during lactation 
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Effect of a low sodium diet in pregnancy on energy and nutrient intake 
The intake of energy and nutrients in the C-group is somewhat lower than reported in 
other studies on Dutch pregnant women (ΙΟ,Π) This is possibly the result of the fact 
that in these studies dietary data were obtained by dietary histories The mean 
nutrient intake assessed by dietary history is often higher than when assessed by 
weighed food records (3) The energy and nutrient intake in the C-group is more in 
agreement with observations in studies on pregnant women from the United Kingdom 
in which weighed food records were used (12,13) 
In the present study the reduction in sodium intake in the pregnant women resulted 
in a significant reduction in intake of energy, protein, carbohydrates, fat, calcium, 
zinc, magnesium, iron and cholesterol Nowson and Morgan (14) studied the effect of 
a low sodium diet (mean urinary sodium excretion during the intervention period 86 
mmol/24h) on energy and nutrient intake in non-pregnant mild hypertensive subjects 
They also observed significant reductions in the intake of energy, carbohydrates, 
protein, fat, calcium and magnesium after the start of the intervention Unfortunately, 
in their control group also significant reductions in the intake of most of these 
nutrients were found and the differences in reductions between the low sodium diet 
group and the control group were not tested statistically A different method of 
dietary assessment was used during the pre-diet phase than during the diet phase, 
which might have been responsible for the observed changes in dietary intake in both 
the control group and the low sodium diet group Furthermore, their dietary 
instructions were also aimed at minimal alterations in potassium intake Significant 
reductions in intake of energy, macronutnents and calcium were also observed in 
pregnant women on a low sodium diet in the study of Steegers et al (11) In this study 
no other micronutnent than calcium was investigated 
The reduction in intake of nutrients in the present study was probably mainly the 
result of the reduced energy intake When the nutrient intake was expressed per 4 2 
MJ energy (1000 kcal, nutrient density) only significant reductions in the nutrient 
densities for fat and sodium were observed in the women on the low sodium diet, 
when compared to the C-group The nutrient densities for carbohydrates, potassium, 
magnesium, iron and dietary fibre even were significantly increased 
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In the women on the ad libitum diet the intake of energy, zinc, magnesium and iron 
was already below the Dutch recommended dietary allowances for pregnant women 
(15). However, these recommendations should be interpreted with caution, since there 
is considerable variation in nutrient requirements among individuals within a 
population and the recommended dietary allowances are set at a level high enough to 
meet the requirements of nearly all healthy individuals (15). Therefore the 
recommended dietary allowances provide a safety factor appropriate to each nutrient 
and exceed the actual requirements of most individuals. But, even when a safety 
factor is taken into account, the results of the present study suggest that a low sodium 
diet during pregnancy increases the risk of an inadequate supply of particularly zinc 
and iron to the mother and fetus. The intake of these two nutrients in the pregnant 
women on the ad libitum diet namely was already respectively 35% and 43% below 
the recommended dietary allowances. 
Although the non-lactating women from the I-group continued the reduced intake of 
some food groups after delivery, this did not result in a significantly different intake 
of energy and nutrients at 6 weeks post partum, when compared to the non-lactating 
women from the C-group. 
The participating women were randomly divided into the I- and C-group, therefore an 
unexpected large difference in energy intake was observed between both groups at 
baseline data collection (week 13 of pregnancy). Also at 6 weeks post partum, 6 
weeks after the intervention was stopped, a comparable difference in energy intake 
between the I- and C-group was found. This confirms that the observed difference at 
baseline was a true difference between the two groups. 
Compliance to the diet 
The aim of the dietary instructions and the guidance of the women on the low sodium 
diet was to arrive at a dietary sodium intake of approximately 20 mmol per day. 
Although their mean urinary sodium excretion during the period of intervention (61 
mmol/24h) suggests that they were not able to adhere to such a strict diet, these 
women still managed to reduce their urinary sodium excretion by more than half their 
usual amount (148 mmol/24h) for a period of approximately 6 months of their 
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pregnancy. The calculated dietary sodium intake in these women (based on food 
consumption data; 35 mmol/d) was more in agreement with the instructed daily 
sodium intake. Several studies reported that calculated dietary sodium intake is less 
than urinary sodium excretion (14,16,17). This is probably due to inadequate food 
composition tables (as a result of variability of the sodium content of food items) and 
the inability to account for added salt during cooking or at the table. However, the 
women on the low sodium diet were not allowed to add salt during cooking or at the 
table. It is possible that the observed difference between calculated dietary sodium 
intake and urinary sodium excretion in these women is due to inaccurate information 
on the sodium content of sodium restricted foods. The possibility that it resulted from 
underreporting because of a desire to adhere well to the diet or from still adding salt 
during cooking or at the table can also not be excluded. In the C-group calculated 
dietary sodium intake was 18% less than urinary sodium excretion (116 versus 142 
mmol/d), which is in line with the results of previous studies in non-pregnant subjects 
on an ad libitum diet (16,17). 
Conclusion 
This study suggests that sodium restriction during pregnancy results in a reduced 
intake of energy, protein, carbohydrates, fat, calcium, zinc, magnesium, iron and 
cholesterol. Since the intake of zinc and iron in pregnant women on an ad libitum 
diet is already far below the recommended dietary allowances, a low sodium diet 
during pregnancy increases the risk of an inadequate supply of particularly these 
important nutrients to mother and fetus. This study also indicates that despite 
extensive instructions and guidance a reduction in sodium intake to 20 mmol daily is 
not practicable for healthy pregnant out-patients. 
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Chapter 4 
LOW SODIUM DIET IN PREGNANCY: 
EFFECTS ON MATERNAL ZINC AND MAGNESIUM STATUS 
Gerrieke D. van der Maten, Joop M.A. van Raaij, Leontien Visman, 
Herman P. Oosterbaan, Rinze de Boer, Lidwien J.M. van der Heijden, 
Joseph G.A.J. Hautvast, Tom К A.B. Eskes 
Abstract 
In this longitudinal study the effects of a low sodium diet in pregnancy on maternal 
zinc and magnesium status were investigated. Ninety-four nulliparous Dutch women 
were randomly allocated to an intervention group (I-group, η = 41), using a low 
sodium diet (mean urinary sodium excretion of 61 mmol/24h) from week 14 of 
pregnancy until delivery and a control group (C-group, η = 53; mean urinary sodium 
excretion of 142 mmol/24h). The dietary intake of zinc and magnesium was 
significantly reduced in the I-group (by 2.1 and 40 mg/d, respectively), when 
compared to the C-group. This reduced intake did not result in significant changes in 
serum zinc, plasma alkaline phosphatase or serum magnesium, probably because of 
homeostatic adaptations by the kidneys. It may be concluded that a low sodium diet 
in pregnancy, as is often prescribed in the Netherlands to prevent or treat 
hypertensive disorders, has no effect on maternal zinc and magnesium status. 
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Introduction 
Sodium restriction during pregnancy has been commonly advised, especially in the 
presence of hypertensive disorders, in the Netherlands. This practice was introduced 
by De Snoo in 1912. He wrote "It would be well if the women were to be forbidden 
the use of salt in the second half of their pregnancy. There would then be far fewer 
cases of serious toxemia, and it would practically put an end to eclampsia" (1). Up till 
now, almost no attention has been given to possible side-effects of such an 
intervention. 
During the period of reproduction the requirements for zinc and magnesium are 
increased (2). An adequate supply of these nutrients during this period may be 
important, as some investigators have suggested a relationship between poor maternal 
zinc or magnesium status and complications of pregnancy and delivery (e.g. 
intrauterine growth retardation, delivery outside of normal term, hypertensive 
disorders and prolonged labor) (3-5). A low sodium diet in pregnancy may reduce the 
intake of these nutrients (6) and thereby adversely affect maternal zinc and 
magnesium status. The present study was carried out to investigate the effects of a 
low sodium diet in pregnancy on dietary zinc and magnesium intake and on 
parameters of zinc and magnesium status in blood and urine. 
Subjects and methods 
Study design 
In this study 94 women were followed longitudinally from early pregnancy until 6 
weeks post partum. After baseline data collection, at week 13 of pregnancy, the 
participating women were randomly allocated (by closed envelope system) to an 
intervention group (I-group), using a low sodium diet from week 14 of pregnancy 
onwards until delivery, and a control group (C-group), continuing their ad libitum 
dietary intake. Food consumption studies and blood and urinary analyses were 
performed during pregnancy and post partum according to the scheme given in Figure 
1. All women visited the antenatal clinic of the hospital Bosch Medicentrum. The 
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study protocol was approved by the Ethical Committee of this hospital Pregnancy 
length was calculated from the first day of the last menstrual period When early 
ultrasonography showed a discrepancy in gestational age of 7 days or more, pregnancy 
length was corrected accordingly (17 out of the 94 pregnancies). 
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FIGURE 1 Scheme of measurements Food consumption study includes energy, sodium, zinc and 
magnesium intake Blood analysis includes hemoglobin, hematocrit, albumin, zinc, total 
alkaline phosphatase (which was only measured at week 13 and 32 of pregnancy and at 1 
and 6 weeks post partum) and magnesium Urinary analysis includes sodium, zinc and 
magnesium excretion 
Subjects 
After extensive information 121 Caucasian nulliparous women with singleton 
pregnancies consented in participation They had no personal history of hypertension 
None of them used any medication at the entry of the study, except for 4 women 
equally divided over both groups investigated, who continuously used vitamin-mineral-
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trace element supplements containing zinc and magnesium (3-5 and 15 mg/d, 
respectively). During the study no vitamin, mineral or trace element containing 
supplements were prescribed except for ferrous (25 women in each group) and folic 
acid (3 women in the I-group and 4 women in the C-group) tablets for the treatment 
of anemia. Magnesium containing antacids were used by 4 women in the I-group and 
8 women in the C-group (containing maximum 700 mg magnesium/d). 
In the I-group 16 women were excluded; 9 women stopped because of difficulties in 
complying to the diet, 1 woman developed a hyperemesis, 3 women used ritodrine for 
several weeks (a tocolytic agent, that may increase sodium and water retention (7)) 
and 3 because of obesity (body mass index ^ 30, since it has been suggested that 
obese people do not report their habitual food intake (8)). Eleven women in the C-
group were excluded; 1 woman stopped because of family problems, 1 switched over 
to a low sodium diet because she developed a hypertensive disorder, 3 women used 
ritodrine for several weeks and 6 were obese. As a result the data of 41 women in the 
I-group and 53 women in the C-group were analysed. The characteristics of these 
women and their infants are given in Table 1. 
Dietary intervention 
The women in the I-group were given verbal and written instructions and were 
carefully guided throughout pregnancy by a trained dietitian. The aim of these 
instructions was to arrive at a dietary sodium intake of approximately 20 mmol (± 
500 mg) per day. The women in the C-group were instructed to maintain their usual 
eating pattern. 
Food consumption 
Food consumption was studied by use of the weighed record method (8). The women 
were instructed to weigh and record each food and drink item before consumption 
and to repeat this procedure on the leftovers at the end of the meal, each time during 
7 consecutive days. Weighing was done on an electronic scale incorporating a zeroing 
button (Type 39308, Tefal SA, Rumilly, France; weighing range 0-4000 g, accuracy ± 
1 g). The amount of salt added during cooking or at the table and the daily intake of 
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TABLE 1 Maternal and infant characteristics 
Intervention Control 
group group 
Number of women 
Age (y)2 
Height (cm)2 
Body weight (kg)2 
Body mass index (kg/m2) 
Pregnancy weight gain (kg) 
Length of gestation (d) 
Number of smokers during pregnancy (% (n)) 
Vaginal delivery (% (n)) 
spontaneous 
Birth weight (g) 
Boys/Girls 
Breast feeding (% (n)) 
41 
29 ± 5 
1679 ± 56 
647 ± 84 
229 ± 2 1 
10 7 ± 4 1 
279 ± 10 
34(14) 
95 (39) 
76 (31) 
3236 ± 481 
22/19 
49 (20) 
53 
28 ± 4 
1675 + 65 
65 8 ± 90 
235 ± 29 
122 ± 39 
278 ± 10 
21 (11) 
94 (50) 
62 (33) 
3207 ± 459 
27/26 
53(28) 
plus minus values are means ± SD 
at entry of study (week 13 of pregnancy) 
3 last recorded body weight dunng pregnancy minus body weight at entry of study 
medicines were not recorded. The records were reviewed with the participants for 
accuracy and completeness by the dietitian. All food and drink items recorded were 
coded according to the Dutch food encoding system (9) and the average daily energy, 
sodium, zinc and magnesium intake was calculated using the Dutch computerized 
food composition table (9). For the present study this food composition table was 
supplemented with data on sodium restricted foods and zinc and magnesium values of 
foods from different literature sources. When no data on zinc and/or magnesium 
contents were available, values were used from similar foods, thus avoiding systematic 
underestimation of zinc and magnesium intake due to missing data 
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Blood and urinary analysis 
Fasting blood samples were collected in EDTA vacuum tubes for the measurement of 
hemoglobin and hematocrit, in lithium heparin gel vacuum tubes for the measurement 
of alkaline phosphatase and albumin and in vacuum tubes without additives for the 
measurement of zinc (metal-free vacutainer, BD, Rutherford, NJ, USA) and 
magnesium (acid-rinsed tubes). Particular attention was paid to avoid environmental 
zinc and magnesium contamination during blood collection and analysis by using 
stainless steel needles, acid-rinsed glassware and pipettes. Heparinized samples were 
centrifuged immediately at 1300 g for 10 minutes. The blood in the plain tubes was 
allowed to clot at room temperature and after centrifugation (2500 g for 10 min) the 
serum was separated. All measurements were done immediately. Hemolytic samples 
were excluded. Serum zinc and magnesium were measured by flame atomic 
absorption spectrophotometry (PU 9000, Pye Unicam, Cambridge, UK) (10). Total 
alkaline phosphatase, a zinc-dependent enzyme (11), was determined using p-
nitrophenyl phosphate and albumin was measured by use of the bromocresol green-
dye binding technique (EPx, Abbott, Chicago, USA) (12,13). Hemoglobin and 
hematocrit were obtained by a hematological cell counter (NE-8000, Sysmex, Kobe, 
Japan). 
Twenty-four hour urine samples were collected in plastic containers (2.5 litres, rinsed 
with 1 N HCl) for the determination of volume, zinc, magnesium and sodium. Urinary 
zinc and magnesium were obtained by flame atomic absorption spectrophotometry 
(PU 9000, Pye Unicam, Cambridge, UK) (10). Urinary sodium was determined by 
flame photometry (Corning 460, Ciba Corning, Halstead, UK). The overall 
coefficients of variation are 4.0% and 2.5% for respectively zinc and magnesium 
(serum as well as urinary) and 3.3%, 2.1% and 1.6% for respectively plasma alkaline 
phosphatase, plasma albumin and urinary sodium. 
For various reasons it was not possible to obtain data of all participants at all stages. 
Results on serum and urinary analyses were obtained on a minimum of 38 and 50 
women for the I- and C-group, respectively, with the exception of week 40 of 
pregnancy due to earlier deliveries (n = 15 for the I-group and η =18 for the C-group) 
and 1 week post partum (at least 32 and 38 women for the I- and C-group, 
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respectively). Albumin was measured in a different way in the early period of the 
study. Therefore only the data on albumin determined as described above were 
analysed (on a minimum of 22 and 27 women for the I- and C-group, respectively, 
again with the exception of week 40 (n = 10 and π = 14)). 
Statistics 
For the analyses of longitudinal data analyses of variance for repeated measurements 
designs were used, followed by Tukey's studentized range tests to compare mean 
values. Changes from baseline values within groups at certain stages of pregnancy and 
post partum were additionally tested by paired t-tests and differences between two 
groups (in changes from baseline values) were tested by two sample t-tests. The 
Shapiro-Wilk test was used to evaluate whether the data were a random sample from 
a normal distribution. Data of some maternal characteristics (smoking, vaginal 
delivery, sex of offspring and breast feeding) were tested using Chi-squared tests. In 
all tests p-values were considered significant at the 5% level. Data analyses were 
carried out using the programme provided by SAS (SAS Institute Ine, Cary, NC, 
USA) (14,15). 
Results 
Urinary sodium excretion 
At week 13 of pregnancy, before the start of the intervention, urinary sodium 
excretion in the intervention group (I-group, 148 ± 62 mmol/24h) did not 
significantly differ from the control group (C-group, 142 ± 54 mmol/24h). During the 
period of intervention (week 14-40 of pregnancy), while in both groups no significant 
changes in urinary sodium excretion were observed, the average urinary sodium 
excretion was 61 ± 30 mmol/24h for the I-group and 142 ± 40 mmol/24h for the C-
group (p< 0.0001). Post partum values were not different from the urinary sodium 
excretion rates at week 13 of pregnancy. The results on urinary sodium excretion are 
described in detail elsewhere (Chapter 2). 
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TABLE 2 Daily energy, sodium, 7ІПС 
Intervention (Ι, η = 41) versus control 
Energy (MJ/d) 
Sodium (mg/d) 
Zinc (mg/d) 
Magnesium (mg/d) 
I 
С 
I 
с 
I 
с 
I 
с 
: and magnesii 
group (C, n = 
wk 133 
9.3 ± 1.7 
8.4 ± 1 6 
2955 ± 853 
2830 ± 619 
10 3 ± 2.4 
97 ± 2.2 
311 ± 72 
278 ± 70 
im intake during pregnancy. ~ 
;53): 
mean wk 
20.28.36 
8.0 ± 1.5 
8.8 ± 1.5 
798 ± 438 
2671 ± 637 
8.2 ± 1.5 
9.7 ± 2.3 
283 ± 61 
290 ± 69 
difference 
-1.3 ± 1.64·5 
0.4 ± 1.34 
-2157 ± 9774'3 
-145 ± 610 
-2.1 ± 1.94'5 
0.0 ± 1.8 
-28 ± 41A-5 
12 ± 52 
values arc means ± SD 
sail added dunng cooking or at the table and daily intake of medicines are not included 
difference significantly different from 0 (p<0 05) 
difference significantly different from difference in control group (p<0001) 
Energy, sodium, zinc and magnesium intake 
In Table 2 daily energy, sodium, zinc and magnesium intake during pregnancy is 
shown. Analyses of variance on the intake of energy and these nutrients did not show 
significant changes within the I- and C-group during the period of intervention. 
Therefore mean intake over this period (week 20, 28, and 36 of pregnancy) was 
taken. Subsequently the changes in intake between intervention period and baseline 
were calculated (see Table 2). Based on these changes, the daily energy, sodium, zinc 
and magnesium intake during intervention was significantly reduced in the I-group by 
1.7 MJ, 2012 mg, 2.1 mg and 40 mg, respectively, when compared to the C-group. 
Hemoglobin, hematocrit and plasma albumin 
Hemoglobin decreased significantly during pregnancy in both groups (by 0.6 ± 0.6 
mmol/1 in the I-group and by 0.6 ± 0.4 mmol/l in the C-group), reaching a nadir at 
72 
CHAPTER 4 F-FFECTS ON ZINC AND MAGNESIUM STATUS 
hemoglobin (mmol/l) 
az-
ao-
7.8-
76-
7.4 
7.2-
_L..i' / V 
Л 
"Π" 
70 ' ι • • ι 
INTERVENTION PERIOD 
I ' ' ' I ' ' ' Ι ' ' ' Ι ' ' ' Ι ' ' ' Ι ' ι 
13 16 20 24 28 32 36 40 1 
τ / ; 
ι/'/ 
Τ ,' ν 
weeks of pregnancy weeks 
posf parfum 
FIGURE 2 Hemoglobin during pregnancy and post partum in tbe intervention group (open circles) and 
control group (Filled circles). Bars represent the SEM. 
week 32 and 28 in the I- and C-group, respectively. The difference in decrease from 
week 13 to 32 between both groups was not significant. Thereafter in both groups a 
comparable increase was observed until week 40 (Figure 2). 
The same pattern was found for hematocrit (Figure 3). A significant decrease until 
week 32 and 28 for respectively the I- and C-group (by 0.02 ± 0.03 and 0.02 ± 0.02 
1/1), followed by a comparable increase in both groups until week 40. The decrease 
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FIGURE 3 Hematocrit during pregnancy and post partum in the intervention group (open circles) and 
control group (filled circles) Bars represent the SEM 
from week 13 to 32 was not significantly different between the two groups. 
In both groups plasma albumin decreased significantly during pregnancy (by 4.6 ± 2.7 
and 5.0 ± 2.3 g/1 from week 13 to 36 in respectively the I- and C-group) (Figure 4). 
The difference in decrease over this period was also not significant. 
At 6 weeks post partum hemoglobin was not significantly different from week 13 of 
pregnancy. However, hematocrit and plasma albumin were significantly increased at 6 
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FIGURE 4 Plasma albumin during pregnancy and post partum in the intervention group (open circles) 
and control group (filled circles). Bars represent the SEM. 
weeks post partum when compared to week 13 of pregnancy in both groups studied. 
Serum zinc, urinary zinc excretion and plasma total alkaline phosphatase 
Figure 5 shows serum zinc during pregnancy and post partum. The significant 
decrease in serum zinc until week 36 of pregnancy was comparable in the I- and C-
group (2.7 ±1.7 and 2.7 ±1.9 umol/1, respectively). Also the increase in serum zinc 
75 
CHAPTER 4 EFFECTS ON ZINC AND MAGNESIUM b'lAI US 
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FIGURE 5 Scrum zinc during pregnancy and post partum in the intervention group (open circles) and 
control group (filled circles). Bars represent the SEM. 
observed in the post partum period was comparable in the two groups. 
Within the I- and C-group a clear and similar increase in urinary zinc excretion was 
observed at the end of pregnancy, reaching only statistical significance at week 40 of 
pregnancy, when compared to week 20-28 of pregnancy in the I-group and to the 
period before week 36 in the C-group (Figure 6). Although in the I-group urinary zinc 
excretion showed a tendency to decrease from week 13 to week 24 of pregnancy 
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FIGURE 6 Urinary ¿ine excretion during pregnancy and posi pari um in the intervention group (open 
circles) and control group (filled circles) Bars represent the SEM 
(ρ = 0.12), this decrease was not significantly different from the change in urinary zinc 
excretion in the C-group over this period. At 6 weeks post partum urinary zinc 
excretion was not significantly different from week 13 of pregnancy in both groups. 
Plasma total alkaline phosphatase (Figure 7) increased significantly during pregnancy 
by 49 ± 18 and 55 ± 28 U/l from week 13 to 32 of pregnancy in respectively the I-
and C-group. The difference in increase was not significant between the two groups. 
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FIGURE 7 Plasma total alkaline phosphatase during pregnancy and post partum in the intervention 
group (open circles) and control group (filled circles) Bars represent the SEM 
At 6 weeks post partum plasma total alkaline phosphatase was still significantly 
elevated, when compared to week 13 of pregnancy in both groups studied. 
Serum magnesium and urinary magnesium excretion 
In both groups a significant decrease of 0.05 ± 0.06 mmol/1 in serum magnesium was 
observed from week 13 to 32 of pregnancy (Figure 8) 
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FIGURE 8 Serum magnesium during pregnancy and posi partum in the intervention group (open 
circles) and control group (filled circles) Bars represent the SEM 
Within both groups no significant changes in urinary magnesium excretion were found 
during pregnancy, although urinary magnesium excretion seemed to increase in the C-
group (Figure 9) The decrease in urinary magnesium excretion from week 13 to 36 of 
pregnancy in the I-group was significantly different from the increase in the C-group 
over this period (p = 0011). 
When compared to week 13 of pregnancy, in both groups serum magnesium was 
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FIGURE 9 Urinary magnesium excretion during pregnancy and posi partum in the intervention group 
(open circles) and control group (filled circles) Bars represent the SEM 
significantly increased and urinary magnesium excretion significantly decreased at 6 
weeks post partum. 
Discussion 
This is, to our knowledge, the first report on the effects of a low sodium diet in 
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pregnancy on maternal zinc and magnesium status. 
The women in the intervention group (I-group) and control group (C-group) were 
comparable with respect to their anthropometric and other characteristics, with the 
exception of a slight but not significant difference in pregnancy weight gain (p = 0.07) 
(Table 1). These characteristics agree well with those previously reported in Dutch 
pregnant women (16,17). In the Netherlands pregnant women are generally guided 
during pregnancy and delivery by midwives and often deliver their babies at home. In 
the present study the women were all guided by obstetricians for different reasons 
(e.g. maternal age, infertility and social reasons). To our opinion, none of these 
reasons will have influenced the results on the variables studied. 
Compliance to the diet 
The women in the I-group had been able to comply reasonably well to the prescribed 
low sodium diet. Their mean urinary sodium excretion during the period of 
intervention (61 mmol/24h) was less than half the amount they were used to (148 
mmol/24h). 
Zinc metabolism in pregnancy on an ad libitum diet 
No significant change in dietary zinc intake was observed during pregnancy, as has 
already been mentioned by other investigators (18,19). The mean zinc intake in this 
study (9.7 mg/d) is in agreement with values reported in the literature (9.1-11.3 
mg/d) (18,19) and with that reported in Dutch non-pregnant subjects (8.4 mg/d) (20). 
The observed significant decline in circulating zinc during pregnancy has been 
reported previously (18,21,22). Possible explanations for this decline include plasma 
volume expansion, hypoalbuminemia, increased levels of estrogens and uptake of zinc 
by the fetus and other products of conception (18,21,22). Some investigators have 
suggested that it reflects suboptimal maternal zinc intake, however, zinc 
supplementation did not prevent the decline (18). 
An increase in urinary zinc excretion at the end of pregnancy was found. This was 
possibly the result of an increased glomerular filtration rate and/or a reduction in the 
affinity of zinc to carrier proteins (5) and has also been described earlier (18,23). 
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Plasma total alkaline phosphatase increased significantly during pregnancy, which is in 
line with the results of other reports (18,19,24). The elevated activity is largely a 
reflection of the placental isoenzyme (25). 
Magnesium metabolism in pregnancy on an ad libitum diet 
The observed daily dietary intake of magnesium (290 mg) is comparable with values 
previously reported in pregnant women by Ashe et al (269 mg) (26) and Gietelink 
(335 mg) (27), but somewhat lower than reported by Skajaa et al in Danish pregnant 
women (445 mg) (28). When corrected for energy intake the daily intake of 
magnesium was still higher in the latter study (± 200 mg per 1000 kcal) than in the 
present study (138 mg per 1000 kcal). 
Serum magnesium declined during pregnancy, as has been observed by other 
investigators (21,29), probably as a result of dilution due to the normal increase in 
plasma volume during pregnancy (29). 
Comparable to the study of Roelofsen et al no significant changes in urinary 
magnesium excretion during pregnancy were found (30). 
Zinc metabolism in pregnancy on a low sodium diet 
The dietary zinc intake in the women on the low sodium diet was significantly 
reduced. This reduction was 20% when compared to baseline values (8.2 versus 10.3 
mg/d). Swanson and King calculated that the amount of dietary zinc required to 
provide maternal-fetal need is 10.5 mg/d, assuming a 25% bioavailability (5). The 
Dutch Nutrition Council suggested that the minimal zinc requirement to compensate 
for losses and growth during the third trimester of pregnancy should be 8.4-10.8 
mg/day (also assuming a 25% bioavailability) (31). According to these calculations, 
the mean dietary zinc intake of 8.2 mg per day in the women on the low sodium diet 
might have been too low to provide maternal-fetal need. 
In spite of this marginal intake, no significant effect of the low sodium diet on serum 
zinc was observed. In the study of Campbell-Brown et al significant lower plasma zinc 
concentrations during pregnancy were found in Hindus (vegetarian and meat eating) 
compared to Europeans and it was suggested that these reflected their lower average 
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dietary zinc intake (7.5, 10.2 and 11.6 mg/d for vegetarian Hindu, meat eating Hindu 
and European pregnant women, respectively) (23). The lower dietary zinc intake in 
the Hindus probably already existed before pregnancy. In our study zinc intake was 
only reduced during the 2nd and 3rd trimester of pregnancy. In non-pregnant subjects 
experimental zinc depletion resulted in decreased serum zinc concentrations. 
However, the intake of zinc during depletion was much lower in these subjects than in 
the pregnant women on the low sodium diet in the present study (0.28-3.5 mg/d 
versus 8.2 mg/d) (11,32). 
Plasma total alkaline phosphatase did not differ between both groups studied. 
Alkaline phosphatase is a zinc-dependent enzyme and reduced concentrations have 
been observed in human zinc deficiency (11,33). During pregnancy total alkaline 
phosphatase comprises the usual non-heat stable fraction plus a heat stable fraction 
produced by the placenta (24). It is not known whether the latter fraction is also zinc-
dependent (19) and its increase during pregnancy may complicate the interpretation 
of total alkaline phosphatase concentration. However, when the data on the non-heat 
stable fraction were analysed separately, also no effect of the diet was found. 
Differences in plasma albumin and/or hematocrit (as an indicator for hemodilution) 
between both groups could have obscured the effects of the low sodium diet on 
circulating zinc and total alkaline phosphatase, but no such differences were observed 
in the present study. 
Although no significant effect of the low sodium diet on urinary zinc excretion during 
pregnancy was found, urinary zinc excretion showed a tendency to decrease during the 
second trimester and was almost constantly lower in the women on the low sodium 
diet, when compared to the C-group. Several studies in non-pregnant subjects report 
that urinary zinc responds to variations in dietary zinc and support the suggestion that 
renal mechanisms operate to preserve zinc homeostasis (11,32,34). 
In non-pregnant subjects zinc absorption and excretion along the gastrointestinal tract 
is influenced by the amount of zinc consumed (34). It is possible that the reduction in 
dietary zinc intake in the women on the low sodium diet was compensated by 
enhanced zinc absorption and reduced zinc excretion in the maternal gut. 
The difference between the I- and C-group in the percentage of women taking iron 
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supplementation during pregnancy (61% and 47% of the women in the I- and C-
group, respectively), although non-significant, might have influenced the results on 
zinc status. Since iron supplementation has been reported to adversely affect zinc 
status (35), this also might have added to a negative effect of the low sodium diet on 
maternal zinc status. 
Magnesium metabolism in pregnancy on a low sodium diet 
In the women on the low sodium diet a significant reduction in dietary magnesium 
intake was observed, without a significant effect on serum magnesium. However, 
when the changes in urinary magnesium excretion from week 13 to 36 of pregnancy 
were compared between the two groups studied, a statistical significant reduction in 
urinary magnesium excretion was observed in the women on the low sodium diet. 
Therefore, to our opinion, although no significant changes in urinary magnesium 
excretion during pregnancy were observed within both groups, an adaptation to the 
reduced dietary magnesium intake by the kidneys in the women on the low sodium 
diet can not be excluded. It has been reported previously that the kidney is an 
important organ in maintaining magnesium homeostasis (36,37). It is also possible 
that the reduced urinary sodium excretion in the women on the low sodium diet 
caused a reduced urinary magnesium excretion. Hills et al showed that urinary 
sodium and magnesium excretion are positively related, independent of dietary 
magnesium intake (38). When the data on serum and urinary magnesium were 
analysed after exclusion of the women using magnesium containing antacids, in both 
groups the same patterns in serum and urinary magnesium were observed as 
described above. 
Mild magnesium deficiency results in an increased release of parathyroid hormone 
and a severe deficiency leads to a decreased release (37). No significant difference in 
serum parathyroid hormone concentrations was found between the two groups 
studied, as is described in detail elsewhere (Chapter 2). 
Conclusion 
This study shows that a low sodium diet during pregnancy, which is commonly 
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prescribed in the Netherlands, significantly reduces dietary zinc and magnesium 
intake, however, without causing a decrease in serum zinc, plasma alkaline 
phosphatase or serum magnesium. Homeostatic adaptations to this reduced dietary 
intake by the kidneys probably play a role. Since serum zinc and magnesium are 
parameters frequently used to assess nutritional status (because of the lack of more 
reliable and sensitive indices), it is concluded that a low sodium diet in pregnancy has 
no effect on maternal zinc and magnesium status. 
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Chapter 5 
LOW SODIUM DIET IN PREGNANCY: 
EFFECTS ON MATERNAL WEIGHT GAIN, FAT ACCUMULATION 
AND PREGNANCY OUTCOME 
Gerrieke D. van der Maten, Joop M.A. van Raaij, Leontien Visman, 
Lidwien J.M. van der Heijden, Rinze de Boer, Herman P. Oosterbaan, 
Tom K.A.B. Eskes, Joseph G.A.J. Hautvast 
Abstract 
The effects of a low sodium diet in pregnancy on maternal weight and fat mass gain 
and pregnancy outcome were studied longitudinally in 94 nulliparous women. They 
were randomly divided into an intervention group (I-group, η = 41), which used a low 
sodium diet (mean urinary sodium excretion of 61 mmol/24h) from week 14 of 
pregnancy until delivery and a control group (C-group, η = 53; mean urinary sodium 
excretion of 142 mmol/24h). When compared to the C-group, non-significant 
reductions in weight gain (1.5 kg) and fat mass gain (0.9 kg) over pregnancy were 
observed in the I-group. If only the data of the women with good compliance (based 
on urinary sodium excretion) were analysed the reductions in weight gain and fat 
mass gain were more pronounced (3.4 kg (p = 0.003) and 1.3 kg (p = 0.15), 
respectively). No significant effects of the diet on infant birth weight, placental weight 
or other pregnancy outcome variables were found. 
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Introduction 
Although there are conflicting data on the recommendations on sodium intake during 
pregnancy, in the Netherlands pregnant women are still advised to reduce their 
sodium intake, especially in the presence of hypertensive disorders. Before proper 
recommendations can be made on sodium intake during pregnancy, it is important to 
have a thorough understanding of the (patho)physiological consequences of a change 
in sodium intake for mother and fetus. To our knowledge only very few studies have 
been conducted on this subject. In these studies sodium restriction, among other 
things, reduced maternal weight gain (1,2) and it was suggested that this was partly 
due to the absence of fat accumulation (2). Maternal weight gain is related to 
pregnancy outcome (3), while fat accumulation during pregnancy is regarded as a 
physiological phenomenon serving as an energy reservoir for late pregnancy and 
lactation (4). Therefore in the present study the effects of a low sodium diet in 
pregnancy on maternal weight gain, fat accumulation and pregnancy outcome are 
investigated. 
Subjects and methods 
Study design 
In 94 women body weight, skinfold thicknesses and urinary sodium excretion were 
measured longitudinally from week 13 of pregnancy until 6 weeks post partum (Figure 
1). In addition, infant birth weight and placental weight were measured. After 
baseline measurements (week 13 of pregnancy) the women were randomly divided (by 
closed envelope system) into an intervention group (I-group) and a control group (C-
group). The women in the I-group used a low sodium diet from week 14 of pregnancy 
onwards until delivery and the women in the C-group continued their ad libitum 
dietary intake. Gestational age was calculated from the first day of the last menstrual 
period. If early ultrasonography showed a discrepancy of more than 7 days, a 
correction was made accordingly (17 out of the 94 pregnancies). Permission for the 
study was obtained from the Ethical Committee of the hospital. 
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FIGURE 1 Scheme of measurements. 
Subjects 
The participants were all Caucasian nulliparous women with singleton pregnancies, 
attending the antenatal clinic of the hospital Bosch Medicentrum. After careful 
explanation of the study 121 women consented in participation. None of them had a 
personal history of hypertension or used any medication at the entry of the study. 
Sixteen of the original 57 women in the I-group were excluded for various reasons; 9 
women withdrew because they experienced the diet as too difficult to comply with, 1 
woman developed a hyperemesis, 3 women used ritodrine for several weeks (a 
tocolytic agent, that may result in increased sodium and water retention (5)) and 3 
obese women (body mass index ^ 30, as measurement of skinfold thicknesses is less 
reliable in obese subjects (6)). In the C-group 11 of the 64 women were excluded; 
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TABLE 1 Maternal and infanl characteristics. 
Number of women 
Age (y)2 
Heighl (cm)2 
Body weight (kg) 
Body mass index (kg/m2) 
Body fat mass (kg) 
Length of gestation (d) 
Number of smokers 
during pregnancy (% (n)) 
Vaginal delivery (% (n)) 
spontaneous 
Boys/Girls 
Birth weight (g) 
Baby length (cm) 
Baby head circumference (cm) 
Apgar score after 1 min 
Apgar score after 5 min 
Arterial pH cord blood 
Arterial base deficit cord 
blood (mmol/1) 
Placental weight (g) 
Breast feeding (% (n)) 
Intervention 
group 
41 
29 ± 5 
167.9 + 5.6 
64.7 ± 8.4 
22.9 ± 2.1 
19 7 ± 4.7 
279 ± 10 
34(14) 
95 (39) 
76 (31) 
22/19 
3236 ± 481 
50 ± 2 
33 ± 2 
9 ± 1 
10 ± 1 
7.21 ± 0.086 
8 ± 5 6 
480 ± 1049 
49 (20) 
Control 
group 
53 
28 ± 4 
167.5 ± 6.5 
65.8 ± 9.0 
23 5 ± 2.9 
21 3 ± 5.2 
278 ± 10 
21(11) 
94(50) 
62 (33) 
27/26 
3207 ± 459 
49 ± 24 
34 ± 2 
9 ± 1 
10 ± 1 
7.22 ± 0.084 
7 ± 4" 
486 ± 85 
53(28) 
Low sodium 
excretion 
group 
24 
29 ± 5 
167.4 ± 5.5 
62.8 ± 8.43 
22.4 ± 2.3 
19 0 ± 4.93 
277 ± 12 
29 (7)3 
96(23) 
71 (17) 
13/11 
3188 ± 432 
49 ± 2 
33 ± 2 
9 ± 2 
10 ± 1 
7.20 ± 0.097 
8 ± 5 7 
478 ± 977 
50 (12) 
High sodium 
excretion 
group 
29 
28 ± 4 
168.8 ± 7.0 
67.8 ± 9.0 
23.8 ± 2.9 
22.2 ± 5.2 
279 ± 10 
7(2) 
97 (28) 
66 (19) 
16/13 
3301 ± 469 
50 ± 25 
34 ± 1 
9 ± 1 
10 ± 1 
7.22 ± 0.095 
7 ± 4 S 
501 ± 85 
55 (16) 
plus minus values are means ± SD 
at entry of study (week 13 of pregnancy) 
significantly different from high sodium excretion group (p<0 05) 
measured without cord and membranes 
9
 η =40 
92 
CHAPTER 5 EFFECTS ON WEIGHT GAIN AND FAT AC'CUMUIATION 
1 woman withdrew for personal reasons, 1 woman switched over to a low sodium diet 
because she developed hypertension, 3 women using ritodrine for several weeks and 6 
because of obesity. As a result the data of 41 women in the I-group and 53 women in 
the C-group were analysed. 
Afterwards, out of these 94 women two subgroups were formed based on their actual 
urinary sodium excretion during the period of intervention. A low sodium excretion 
group (LSE-group; η = 24) with a maximum urinary sodium excretion during the 
period of intervention of 60 mmol/24h and a high sodium excretion group (HSE-
group; η = 29) with a minimum urinary sodium excretion of 140 mmol/24h. All but 
one woman in the LSE-group originated from the I-group and all women in the HSE-
group originated from the C-group. Characteristics of the participants are shown in 
Table 1. 
Dietary intervention 
The women in the I-group received oral and written dietary instructions from and 
guidance by a trained dietitian throughout pregnancy. The dietary instructions were 
based on a dietary sodium intake of approximately 20 mmol (± 500 mg) per day. The 
women in the C-group were instructed to maintain their usual eating pattern. 
Maternal body weight and fat mass 
Body weight was measured on an electronic scale (Mettler TE/J, Mettler Instrumente 
AG, Greifensee, Switzerland; weighing range 2.50-120.00 kg, accuracy 0.05 kg), with 
the women wearing minimal clothing. On all subjects skinfold thicknesses were 
measured at four sites of the body (triceps, biceps, suprailiac and subscapular (7)). 
The readings were done, generally by one person, on the left side of the body in 
triplicate using a Holtain caliper (Holtain Ltd, Crymych, UK; correct to 0.2 mm). 
Body density of each individual was derived from the sum of the averages of the four 
skinfold thicknesses using the equations from Durnin and Womersley (8). Body fat 
mass was calculated from body density and body weight using Siri's equation (9). 
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Infant and placental weight 
Immediately after delivery the weight of the infant was measured by the nurse in the 
delivery room on a spring balance (type Piccolo, Berkel, Rotterdam, The Netherlands, 
accuracy ± 10 g) or electronic scale (type 680MKII, Berkel, accuracy ± 5 g) The 
placental weight was measured without cord and membranes on a spring balance 
(Soehnle, Murrhardt, Germany, accuracy ± 10 g) by the physician on duty or his 
intern. 
Urinary sampling and analysis 
Twenty-four hour urine samples were collected in plastic containers for the 
determination of volume and sodium Urinary sodium was measured by flame 
photometry (Corning 460, Ciba Corning, Halstead, UK) 
Statistics 
Data analyses were performed on the SAS statistical package (SAS Institute Ine, 
Cary, NC, USA) (10,11) To evaluate whether the data were a random sample from a 
normal distribution Shapiro-Wilk tests were used Longitudinal data were analysed by 
repeated-measures analyses of variance Tukey's studentized range tests were used to 
compare mean values in case of significant changes during pregnancy or post partum 
In addition, post partum changes from baseline values within groups were also tested 
by paired t-tests. To test differences (in changes from baseline) between two groups 
two sample t-tests were performed. Data of some maternal and infant characteristics 
(smoking, vaginal delivery, infant sex and breast feeding) were tested using Chi-
squared tests P-values less then 0.05 were considered significant 
Results 
Unnary sodium excretion 
Before the start of the intervention (week 13 of pregnancy) no significant difference 
in urinary sodium excretion was observed between the intervention group (I-group, 
148 ± 62 mmol/24h) and the control group (C-group, 142 ± 54 mmol/24h). No 
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significant changes in urinary sodium excretion were found throughout the period of 
intervention (week 14-40 of pregnancy) The mean urinary sodium excretion over this 
period in the I-group (61 ± 30 mmol/24h) was significantly lower than in the C-group 
(142 ± 40 mmol/24h) (p< 0 0001) Post partum values of urinary sodium excretion 
were comparable to those at week 13 of pregnancy 
In the low sodium excretion group (LSE-group) mean urinary sodium excretion 
during intervention was 40 ± 11 mmol/24h, which was significantly lower than the 
169 ± 29 mmol/24h in the high sodium excretion group (HSE-group) (p< 0 0001) 
The results on urinary sodium excretion are described in detail elsewhere (Chapter 
2) 
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FIGURE 2A Maternal weight gain during pregnancy and post partum in the intervention group (open 
circles) and control group (filled circles) Bars represent the SEM 
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Weight gam over pregnancy 
Maternal weight gain, as calculated from week 13 of pregnancy, in the I- and C-group 
is shown at various stages during pregnancy and post partum in Figure 2a. Maternal 
weight gain over pregnancy (last recorded body weight during pregnancy minus body 
weight at entry of study) was 10.7 ± 4.1 kg in the I-group and 12.2 ± 3.9 kg in the C-
group. The difference in weight gain of 1.5 kg between both groups was not 
significant (p = 0.07). 
The results on maternal weight gain during pregnancy and post partum for the LSE-
and HSE-group are shown in Figure 2b. A highly significant reduction in weight gain 
weigh)" gain (kg) 
16 
13 16 
weeks of pregnancy 
»-;- , ΐ 
1
 I ' ' ' I ' Ι ι ' ' ' ι 
36 40 1 2 6 
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post parfum 
FIGURE 2B Maternal weight gain during pregnancy and post partum in the low sodium excretion group 
(open squares) and high sodium excretion group (filled squares) Bars represent the SEM 
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FIGURE 3 Frequency distributions of weight gain over pregnancy (last recorded body weight during 
pregnancy minus body weight at week 13 of pregnancy), tat mass gain over pregnancy 
(difference in fat mass between 2 weeks post partum and week 13 of pregnancy) and birth 
weight, for the intervention group (striped bars) and control group (filled bars) on the left 
side and for the low bodium excretion group (open bars) and high sodium excretion group 
(dotted bars) on the right side. 
97 
CHAPTERS Γ III CTS 0 \ WhlGHT GAIN AND ΓΑ 1 ACCUMULATION 
of 3.4 kg was observed in the LSE-group, when compared to the HSE-group 
(p<0.01). The maternal weight gain over pregnancy being 9.5 ± 4.4 kg and 12.9 ± 3.4 
kg in the LSE- and HSE-group, respectively. 
Frequency distributions of individual values of weight gain over pregnancy are given 
in Figure 3. 
Body weight and fat mass in early pregnancy and post partum 
Maternal body weight and fat mass at week 13 of pregnancy (baseline value) and at 2 
and 6 weeks post partum are shown in Table 2. In addition, changes in these 
parameters at 2 and 6 weeks post partum from baseline are also given in Table 2. In 
the I- and C-group and the HSE-group body weight at 2 and 6 weeks post partum was 
significantly increased, compared to baseline. However, in the LSE-group body weight 
at 2 and 6 weeks post partum did not differ significantly from baseline values. With 
the exception of a significant increase in fat mass in the C-group at 2 weeks post 
partum, no significant changes in fat mass were observed at 2 and 6 weeks post 
partum, when compared to baseline values, in all groups studied. 
Based on the differences between post partum and baseline values, body weight and 
fat mass increments at 2 weeks post partum in the I-group were reduced by 1.5 kg 
(p = 0.058) and 0.9 kg (p = 0.142) respectively, when compared to the C-group. These 
reductions in body weight and fat mass increments were more pronounced for 
Iactating women (2.5 and 2.0 kg, respectively) than for non-lactating women (0.7 and 
0.0 kg, respectively) (Table 3). 
Based on the differences between post partum and baseline values, body weight and 
fat mass increments at 2 weeks post partum in the LSE-group were reduced by 2.8 kg 
(p = 0.014) and 1.3 kg (p = 0.147) respectively, when compared to the HSE-group 
(Table 2). 
Frequency distributions of the individual data on fat mass gain over pregnancy 
(difference in fat mass between 2 weeks post partum and baseline) are shown in 
Figure 3. 
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TABLE 2 Body 
wk 13 of pregn. 
wk 2 p.p. 
wk 6 p.p. 
Û wk 2 p.p. 
û wk 6 p.p. 
wk 13 of pregn. 
wk 2 p.p. 
wk 6 p.p. 
Û wk 2 p.p. 
û wk 6 p.p. 
weight and fat mass in early pregnancy and 
η 
41 
39 
41 
39 
41 
η 
24 
23 
24 
23 
24 
Intervention | 
Weight 
(kg) 
64.7 ± 8.4 
66.3 ± 8.3 
66.3 ± 8.5 
1.4 ± 3.82 
1.6 ± 4.03 
η 
41 
38 
40 
38 
40 
'roup 
Fat mass 
(kg) 
19.7 ± 4.7 
20.0 ± 4.6 
20.3 ± 4.9 
0.0 ± 3.2 
0.7 ± 2.9 
Low sodium 
excretion group 
Weight 
(kg) 
62.8 ± 8.4 
63.6 ± 6.5 
63.8 ± 6.7 
0.4 ± 4.54 
0.9 t 4.6 
η 
24 
23 
23 
23 
23 
Fat mass 
(kg) 
19.0 ± 4.9 
18.7 ± 4.1 
19.0 ± 4.4 
-0.5 ± 3.5 
0.3 ± 3.2 
post partum (all women). 
η 
53 
49 
53 
49 
53 
η 
29 
28 
29 
28 
29 
Control 
Weight 
(kg) 
65.8 ± 9.0 
68.8 ± 9.2 
68.0 ± 9.2 
29 ± 3.72 
2.2 ± 3.83 
group 
η 
53 
49 
53 
49 
53 
High sodium 
excretion 
Weight 
(kg) 
67.8 ± 9.0 
70.6 ± 8.7 
70.1 ± 8.8 
3.2 ± 3.42 
2.3 ± 3.63 
group 
η 
29 
28 
29 
28 
29 
Fat mass 
(kg) 
21.3 ± 5.2 
22 2 ± 5.1 
22 0 ± 5.1 
0.9 ± 2.62 
0.7 ± 2 9 
1 
Fat mass 
(kg) 
22.2 ± 5.2 
22.7 ± 5.0 
22.6 ± 4.9 
0.8 ± 2.6 
0.4 ± 2.9 
values are means ± SD 
change from week 13 of pregnancy to 2 weeks post partum significantly different from 0 (p<0 05) 
3
 change from week 13 of pregnancy to 6 weeks post partum significantly different from 0 (p<0 05) 
change from week 13 of pregnancy to 2 weeks post partum significantly different from change in 
high sodium excretion group (p<005) 
Birth weight and placental weight 
No significant differences in infant birth weight or placental weight were found 
between the I- and C-group, nor between the LSE- and HSE-group (Table 1). 
Frequency distributions of the birth weight data are given in Figure 3. 
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TABLE 3 Body weight and fai mass in early pregnancy and post partum in lactating and non lattating 
women intervention versus control group 
Lactating women 
wk 13 of pregn 
wk 2 p p 
wk 6 ρ ρ 
Û wk 2 ρ ρ 
Û wk 6 ρ ρ 
η 
20 
19 
20 
19 
20 
Intervention 
Weight 
(kg) 
65 7 ± 9 0 
67 0 ± 8 6 
668 ± 91 
0 7 ± 2 82 
11 ± 34 
η 
20 
18 
19 
18 
19 
group 
Fat mass 
(kg) 
19 9 ± 5 4 
194 ± 50 
199 ± 56 
11 ± 2 32 
0 3 ± 24 
η 
28 
26 
28 
26 
28 
Control 
Weight 
(kg) 
65 9 ± 9 5 
69 4 ± 9 5 
681 ± 95 
3 2 ± 3 83 
23 ± 3 7 4 
group 
η 
28 
26 
28 
26 
28 
Fai mass 
(kg) 
207 + 53 
217 ± 52 
215 ± 54 
09 ± 27 
08 ± 30 
Non lactating women 
wk 13 of pregn 
wk 2 p p 
wk 6 p p 
Û wk 2 ρ ρ 
Û wk 6 ρ ρ 
Intervention group 
η Weight 
(kg) 
21 63 7 ± 7 9 
20 65 7 ± 8 1 
21 65 8 ± 8 1 
20 2 0 + 4 6 
21 2 1 ± 4 6A 
η Fai mass 
(kg) 
21 196 + 40 
20 205 ± 44 
21 206 ± 4 3 
20 09 ± 36 
21 10 + 33 
Control group 
η Weight 
(kg) 
25 65 8 ± 8 6 
23 68 1 ± 9 0 
25 679 + 92 
23 27 ± 3 7 3 
25 2 1 ± 4 04 
η Fat mass 
(kg) 
25 22 1 ± 5 1 
23 227 ± 49 
25 226 ± 47 
23 09 + 25 
25 05 ± 28 
values arc means + SD 
о 
change from week 13 of pregnancy to 2 weeks post partum significantly different from change in control group (p < 0 0 )^ 
change from week 13 of pregnancy to 2 weeks post partum significantly different from 0 (p<0 01) 
change from week 13 of pregnancy to 6 weeks post partum significantly different from 0 (p<0 05) 
Discussion 
No significant differences were observed between the intervention group (I-group) 
and the control group (C-group) with regard to the characteristics of the participants 
(Table 1) Their characteristics are comparable with those previously reported in 
Dutch pregnant women (12,13) Between the low sodium excretion group (LSE-
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group) and high sodium excretion group (HSE-group) significant differences in body 
weight and body fat mass at the entry of the study and number of smokers during 
pregnancy were observed. The women in the present study were all guided during 
pregnancy and delivery by obstetricians for various reasons, while usually in the 
Netherlands pregnant women are guided by midwives and they often deliver their 
babies at home. To our opinion, these reasons (e.g. infertility, maternal age, social 
reasons) will not have influenced the results on the variables studied. 
Compliance to the diet 
In spite of intensive guidance the women in the I-group were not able to adhere 
strictly to the prescribed diet, since their mean urinary sodium excretion during the 
period of intervention (61 mmol/24h) overreached three times the instructed sodium 
intake (20 mmol per day). Nevertheless, these pregnant women managed to reduce 
their urinary sodium excretion for half a year by more than half their usual amount 
(148 mmol/24h). 
Pregnancy weight gain, fat accumulation and pregnancy outcome in women on an ad 
libitum diet 
Hytten (14) accepted the value of 12.5 kg as an appropriate estimate for total weight 
gain over pregnancy in healthy Primigravidae eating without restriction. This estimate 
is mainly based on the studies of Humphreys (15) and Thomson and Billewicz (16). 
The weight gain over pregnancy observed in the present study (12.2 kg from week 13 
of pregnancy) is in accordance with their results. A remarkable large individual 
variation in weight gain over pregnancy was found, as has already been mentioned by 
Hytten (14) (Figure 3). 
Weight retentions at 2 and 6 weeks post partum (2.9 and 2.2 kg, respectively) are also 
in agreement with earlier reports (13,17,18). 
A significant increase in fat mass over pregnancy of 0.9 kg was observed. In earlier 
studies, in which corresponding measurement periods and the skinfold method were 
used, comparable results were found (13,18-20). However, in other studies larger fat 
mass gains were reported (21-24). Also in the fat mass gain over pregnancy a striking 
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high degree of inter-individual variability was found (Figure 3), as has been observed 
by others (13,21,23,24). Data on body composition changes during pregnancy are 
based on assumptions that may not be valid in pregnancy or are drawn from partly 
theoretical estimates of changes in various compartments (25). In the present study 
body fat was calculated using equations derived from non-pregnant women. Therefore 
that method was only used in early pregnancy and post partum and the estimate of fat 
mass increase during pregnancy was based on the difference in fat mass between 2 
weeks post partum and week 13 of pregnancy. 
The birth weights of the babies are in agreement with those described in other Dutch 
studies (12,13). The placental weights are also comparable with those earlier reported 
in Dutch women (26). 
Pregnancy weight gain, fat accumulation and pregnancy outcome in women on a low 
sodium diet 
The low sodium diet reduced maternal weight gain over pregnancy, although this 
effect seemed to be obscured by the fact that not every women in the I-group 
adhered strictly to the diet, since it only reached statistical significance when the 
women were rearranged according to their actual urinary sodium excretion during 
intervention (LSE- and HSE-group). However, the large reduction in maternal weight 
gain observed in pregnant women on a low sodium diet in the comparable study of 
Steegers et al (± 6 kg) (2) was not found in the present study. This cannot be 
explained by less compliance to the low sodium diet, since mean urinary sodium 
excretion in the LSE-group was comparable with that reported in the study of 
Steegers et al. The relative small sample size in both studies was possibly responsible 
for the difference, since a large individual variation in weight gain over pregnancy was 
observed, even in the LSE-group. 
The reduced maternal weight gain during sodium restriction was probably partly due 
to a reduced extracellular fluid volume expansion (1,2,27,28). The largest reduction in 
weight gain was found immediately after the start of the intervention (week 13 to 16 
of pregnancy), possibly resulting from a readjustment of the extracellular fluid volume 
to a lower sodium intake, as has been reported in non-pregnant subjects (29,30). 
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The women on the low sodium diet tended to reduce fat accumulation over 
pregnancy, which also may have partly accounted for the reduced weight gain. This 
tendency to reduce fat mass gain is also demonstrated by the reductions in weight 
retention at 2 weeks post partum in these women, assuming that by that time the 
extra weight of the mother would be mainly body fat (18). The reduced fat 
accumulation was possibly the result of the observed reduced energy intake in 
pregnant women on a low sodium diet, as is described in detail elsewhere (Chapter 
3). Emerson stated that fat accumulation during pregnancy is reduced when caloric 
intake is restricted (31). On average, in the LSE-group even a loss of fat over 
pregnancy was observed, indicating overall mobilization of adipose tissue, probably to 
maintain energy balance. 
Although the low sodium diet reduced maternal weight gain, it did not affect birth 
weight. Weight gain over pregnancy is related to birth weight, however, the 
correlation is not particularly close (14). It is important to mention that the present 
study had a statistical power of 80% to detect a difference in birth weight of 291 g 
between the I- and C-group. Consequently a smaller reduction in birth weight, which 
still might be of physiological importance, had a lesser chance of being detected. 
Whether maternal fat accumulation is essential for good fetal growth is still unknown. 
Several authors (21,23,32) did not observe a significant relationship between maternal 
fat mass gain and birth weight. In contrast to their results Villar et al (22) did observe 
a significant relation. However, when the data were analysed by different periods of 
pregnancy it was demonstrated that only body fat deposition between week 6 and 19 
of pregnancy was associated with birth weight. As mentioned above, in the present 
study in the women considered to have adhered very well to the diet (LSE-group) 
even an overall fat loss over pregnancy was observed without an effect on birth 
weight. Also no effects of the diet on other variables of pregnancy outcome were 
found (Table 1). 
For reasons that remain inexplicable, the differences between the I- and C-group in 
weight retention post partum and maternal fat mass gain were more pronounced in 
the lactating than in the non-lactating women. This was also true for the difference 
between the I- and C-group in weight gain over pregnancy (2.1 and 0.9 kg for 
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lactating and nun-lactating women, respectively). 
The women in the present study were all healthy and well-nourished. It is possible 
that in women who begin pregnancy with a reduced body weight or depleted maternal 
fat stores the use of a low sodium diet in pregnancy increases the risk for impaired 
fetal growth. 
In conclusion, the results of this study suggest that in women using a low sodium diet 
during pregnancy, which is still commonly prescribed in the Netherlands, weight gain 
is reduced, probably due to a reduced extracellular fluid volume expansion and partly 
also as a result of a reduced fat accumulation, without major effects on pregnancy 
outcome. 
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Chapter 6 
GENERAL DISCUSSION 
Although during pregnancy a low sodium diet is commonly prescribed as a preventive 
and therapeutic measure in hypertensive disorders in the Netherlands, possible side-
effects of such a diet are largely unknown. In order to increase our knowledge on this 
subject, in the present study, besides a possible effect on blood pressure, the effects of 
a low sodium diet in pregnancy on maternal energy and nutrient intake, calcium 
metabolism, zinc and magnesium status, weight gain and body fat storage were 
investigated. Since there are indications that nutrition, mineral and trace element 
status and body composition are related to pregnancy outcome, in affecting these 
variables a low sodium diet may have implications for the health of the mother and 
fetus. 
In spite of the fact that randomization took place, significant differences were 
observed between the intervention and control group in baseline values of some of 
the variables studied (diastolic blood pressure and mean arterial pressure in sitting 
and in left lateral recumbent position, the intake of energy and several nutrients and 
urinary magnesium excretion). The possibility that these differences occured as a 
result of the exclusion of the women who withdrew from the study because they 
experienced the diet as too difficult to comply with was rejected, because after 
including their data most significant differences remained. To our opinion, the 
consequences of these differences for the results of the present study are limited, 
since in this longitudinal study only changes from baseline values were used for 
statistical testing. 
Success of the intervention 
The present study demonstrates that it is possible to persuade well-motivated healthy 
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pregnant outpatients to reduce their sodium intake for a longer period of time. 
Urinary sodium excretion represents 90 to 95% of ingested sodium (1). Therefore, the 
urinary sodium excretion rates in the intervention group suggest that, although the 
sodium intake was reduced by more than half, most women were not able to lower 
their sodium intake to the instructed 20 mmol per day. It has been stated previously 
that such a steep reduction in sodium intake cannot be realized outside a specialized 
metabolic unit or hospital (2,3). The urinary sodium excretion rates during 
intervention (mean 61 mmol/24h; range 20-135 mmol/24h) indicate that the results of 
the present study are based on a reduction in sodium intake to on average 
approximately 66 mmol/day. When compared to the normal sodium intake during 
pregnancy (154 mmol/24h) this reduction is still very large and highly significant and 
apparently the maximum attainable when prescribing a low sodium diet to healthy 
pregnant outpatients on a voluntary basis. 
The effect of a low sodium diet in pregnancy on blood pressure 
The present study indicates that such a reduction in sodium intake during pregnancy 
will not have an effect on the course of blood pressure. Even after rearranging the 
participating women according to their actual urinary sodium excretion rates during 
intervention (low sodium excretion group (LSE-group; urinary sodium excretion й 60 
mmol/24h, mean 40 mmol/24h) versus high sodium excretion group (HSE-group; 
urinary sodium excretion ¿ 140 mmol/24h, mean 169 mmol/24h)), in this way 
excluding the women who did not comply very well to the diet, also no effect of 
sodium restriction during pregnancy on the course of blood pressure was found. The 
low sodium diet also did not have an effect on the incidence of hypertensive disorders 
of pregnancy. However, since the sample size in the present study is much too small 
for a definitive conclusion on the prophylactic effect of a low sodium diet on 
hypertensive disorders of pregnancy, the results of the multicenter trial remain to be 
evaluated. 
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The effect of a low sodium diet in pregnancy on energy and nutrient intake 
The hypothesis that eliminating foods with a high sodium content from the diet may 
reduce the intake of other essential nutrients, already described by Engstrom and 
Tobelmann (4), proved to be true The reduction in sodium intake during pregnancy 
also caused a significant reduction in the intake of energy, protein, carbohydrates, fat, 
calcium, zinc, magnesium, iron and cholesterol The substantial reduction in sodium 
intake was partly achieved through a significantly decreased consumption of several 
food groups, which also contribute to the daily intake of other important nutrients 
For example, the intake of grain products and milk and dairy products was 
significantly reduced in the women on the low sodium diet, while these food groups 
also contribute much to the daily intake of calcium, zinc, magnesium and iron (5) 
The reduced intake of energy and several nutrients in the women on the low sodium 
diet increased the risk of an inadequate supply of nutrients to mother and fetus This 
particularly applied for the reduced intake of zinc and iron, since the intake of these 
nutrients in the control group was already far below the Dutch recommended dietary 
allowances for pregnant women (respectively 35% and 43% below the recommended 
dietary allowances) (5) 
The effects of a low sodium diet in pregnancy on maternal calcium metabolism and 
zinc and magnesium status 
The significant reduced dietary intake of calcium, zinc and magnesium in the women 
on the low sodium diet did not result in changes in circulating total calcium, ionized 
calcium, parathyroid hormone, zinc, alkaline phosphatase or magnesium This was, at 
least in part, probably due to reductions in the urinary excretion of these nutrients 
These reduced urinary excretions may have been homeostatic adaptations (6-8) 
and/or consequences of the reduced urinary sodium excretion, since positive and 
direct relationships between the excretion of sodium and calcium and sodium and 
magnesium by the kidneys have been reported previously (9-11) 
The results of the present study suggest that, although a low sodium diet during 
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pregnancy may reduce the dietary intake of calcium, zinc and magnesium, it will not 
have an effect on several indices of calcium metabolism, nor will it adversely affect 
maternal zinc and magnesium status. 
Serum concentrations of zinc and magnesium are parameters frequently used to 
assess zinc and magnesium status, because they are easy to measure and because 
there is a lack of more sensitive and reliable indices. However, the fact that they may 
not always reflect total body zinc and magnesium limits the interpretation of the 
results on serum zinc and magnesium in the present study (8,12). 
The effect of a low sodium diet on maternal body composition 
The use of a low sodium diet in pregnancy resulted in a поп-significant reduction in 
maternal weight gain over pregnancy of 1.5 kg. The reduction in weight gain was 
larger (3.4 kg) and statistically significant when the women were rearranged according 
to their actual urinary sodium excretion rates during the period of intervention (LSE-
group versus HSE-group). However, the large reduction in weight gain of 
approximately 6 kg in women on a low sodium diet during pregnancy reported in the 
study of Steegers (13), which was part of the multicenter trial, was not found in the 
present study. This cannot be explained by less compliance to the prescribed diet, 
since mean urinary sodium excretion in the LSE-group was comparable with that 
reported in his study. It is possible that the relative small sample size in both studies 
was responsible for this difference, since a large individual variation in weight gain 
over pregnancy was observed, even in the women in the LSE-group. Steegers 
suggested that the reduced weight gain was partly due to an absence of fat 
accumulation or even loss of fat during pregnancy. Therefore in the present study 
skinfold thicknesses were measured to obtain information on body fat mass. The 
women on the low sodium diet did show a tendency to reduce fat accumulation over 
pregnancy (by 0.9 kg in the intervention group, and by 1.3 kg in the LSE-group), 
however, these reductions did not reach statistical significance. The degree of 
hydration of the subcutaneous tissues influences the thickness of the skinfolds and the 
accumulation of water during pregnancy may therefore reduce the validity of the 
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estimates of fat mass from skinfold thicknesses (14). It is however unlikely that such 
bias occured in the present study, since skinfold thicknesses were only measured in 
early pregnancy and post partum, assuming that at these time periods the 
accumulation of water in the subcutaneous tissues is negligible. Furthermore, at these 
time periods intervention was not yet started or already stopped, ruling out the 
possibility that differences in the accumulation of water during pregnancy between the 
groups studied influenced the results. Some authors have shown that some skinfolds 
increase more than others during pregnancy, indicating that fat deposition during 
pregnancy is not equally spread over all adipose tissues (15-17). This is particularly so 
for the mid-thigh skinfold. The mid-thigh region is not included in the traditional 4 
site measurement (18), which has been used in the present study. Therefore fat 
accumulation during pregnancy and the difference in fat accumulation between the 
two groups studied may have been underestimated. In contrast, Butte et al (19) 
concluded that specific equations for lactating women are not necessary. 
The tendency to reduce fat accumulation in the women on the low sodium diet was 
probably the result of a reduced energy intake (20,21). 
The present study indicates that a low sodium diet in pregnancy reduces maternal 
weight gain, probably due to a reduction in extracellular fluid volume expansion and 
partly also as a result of a reduced fat accumulation. 
Conclusion 
The prescription of a low sodium diet in pregnancy resulted in a reduced intake of 
energy and several nutrients. Nevertheless, the pregnant women appeared to be able 
to adapt quite well to this reduced intake, since calcium, zinc and magnesium 
homeostasis was maintained. This was probably due to a reduced renal excretion of 
these nutrients. Also other physiological adaptations might have played a role, such as 
an increased intestinal absorption. Although maternal weight gain was reduced, no 
effect of the low sodium diet on infant birth weight, which is generally considered to 
be the best measure of the quality of pregnancy (14), was found. Therefore, the 
results of the present study give no rise to advise against sodium restriction in healthy 
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well-nourished Dutch pregnant women. However, one must bear in mind that, 
because of the limitations of the parameters used, it still cannot fully be excluded that 
a low sodium diet in pregnancy reduces body stores of calcium, zinc and magnesium. 
In the light of lack of a beneficial effect of the low sodium diet on blood pressure and 
the incidence of hypertensive disorders, the prescription of such a diet as a 
prophylactic measure in pregnancy should not be advocated. 
For a definitive conclusion on the recommendation on sodium intake during 
pregnancy the results of the multicenter trial and the results on the side-effects of a 
low sodium diet studied by the other participating hospitals remain to be seen. 
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SUMMARY 
Since there seemed to be no controlled studies that allow firm conclusions about the 
value of dietary sodium restriction during pregnancy, a multicenter controlled 
randomized study was initiated in the Netherlands to evaluate the prophylactic effect 
of a low sodium diet during pregnancy on hypertensive disorders. However, before 
proper recommendations on sodium intake during pregnancy can be made, it is 
important to have a thorough understanding of the (patho)physiological consequences 
of a change in sodium intake for mother and fetus. Only very few studies have been 
conducted on this subject and therefore each participating hospital also investigated 
different side-effects of a low sodium diet in pregnancy. In the hospital Bosch 
Medicentrum in 's-Hertogenbosch the multicenter study protocol was extended in 
such a way that the effects of a low sodium diet on maternal energy and nutrient 
intake, calcium metabolism, zinc and magnesium status, weight gain and body fat 
storage were also investigated. Since there are indications that these variables are 
related to pregnancy outcome, in affecting these variables a low sodium diet may 
have implications for the health of the mother and fetus. In the present thesis the 
results of the study conducted in the hospital Bosch Medicentrum are described. 
Ninety-four nulliparous women were studied longitudinally from early pregnancy until 
6 weeks post partum. They were randomly divided into an intervention group (n=41), 
which used a low sodium diet (mean urinary sodium excretion of 61 mmol/24h) from 
week 14 of pregnancy onwards until delivery and a control group (n = 53), which 
continued their ad libitum dietary intake (mean urinary sodium excretion of 142 
mmol/24h). Measurements were performed in both groups before the start of the 
intervention (week 13 of pregnancy), thereafter about every 4 weeks until delivery 
and at 1, 2 and 6 weeks post partum. 
No effect of the low sodium diet in pregnancy on the course of blood pressure and 
the incidence of hypertensive disorders was observed (Chapter 2). The reduction in 
sodium intake during pregnancy also caused a significant reduction in the intake of 
energy, protein, carbohydrates, fat, calcium, zinc, magnesium, iron and cholesterol 
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(Chapter 3). This reduced intake of energy and several nutrients increased the risk for 
an inadequate supply of nutrients to mother and fetus. This particularly applied for 
the reduced intake of zinc and iron, since the intake of these micronutrients in the 
control group was already far below the Dutch recommended dietary allowances for 
pregnant women (respectively 35% and 43% below the recommended dietary 
allowances). In the women on the low sodium diet a significantly reduced urinary 
calcium excretion was found (Chapter 2). Changes in dietary calcium intake appear to 
alter urinary calcium excretion mainly by altering the secretion of parathyroid 
hormone. However, no change in circulating parathyroid hormone was found in the 
women on the low sodium diet. Therefore, the reduced urinary calcium excretion was 
more likely due to the reduced urinary sodium excretion. A direct and positive 
relationship between urinary sodium and calcium excretion has been reported 
previously. The reductions in dietary calcium intake and urinary calcium excretion 
probably counterbalanced each other, resulting in an absence of changes in circulating 
total calcium, ionized calcium and parathyroid hormone in the women on the low 
sodium diet during pregnancy (Chapter 2). The significant reduced intake of zinc and 
magnesium in the women on the low sodium diet did not result in significant changes 
in serum zinc, plasma alkaline phosphatase or serum magnesium, probably because of 
homeostatic adaptations by the kidneys (Chapter 4). Thus, sodium restriction during 
pregnancy had no effect on maternal zinc and magnesium status. In the women on 
the low sodium diet non-significant reductions in weight gain (1.5 kg) and fat mass 
gain (0.9 kg) over pregnancy were observed (Chapter 5). These reductions in weight 
and fat mass gain were more pronounced (3.4 kg (p=0.003) and 1.3 kg (p = 0.15), 
respectively), when only the data of the women with good compliance (based on their 
urinary sodium excretion during intervention) were analysed. It is concluded that a 
low sodium diet in pregnancy reduces maternal weight gain, probably due to a 
reduced extracellular fluid volume expansion and partly also as a result of a reduction 
in fat accumulation. No significant effects of a low sodium diet on infant birth weight, 
placental weight or other pregnancy outcome variables (length and head 
circumference of the infant, apgar scores and arterial pH of the cord blood) were 
found (Chapter 5). 
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In the present study the prescription of a low sodium diet in pregnancy resulted in a 
reduced intake of energy and several nutrients. Nevertheless, the pregnant women 
appeared to be able to adapt quite well to this reduced intake, since calcium, zinc and 
magnesium homeostasis was maintained. Also no effect on infant birth weight, 
considered to be the best measure of the quality of pregnancy, was found. Therefore 
the results of the present study give no rise to advise against sodium restriction in 
healthy well-nourished Dutch pregnant women. However, in the light of lack of a 
beneficial effect of the low sodium diet on blood pressure and the incidence of 
hypertensive disorders the prescription of such a diet as a prophylactic measure in 
pregnancy should not be advocated. For a definitive conclusion on the 
recommendation on sodium intake during pregnancy the results of the multicenter 
trial and the results on the side-effects of a low sodium diet studied by the other 
participating hospitals remain to be seen. 
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SAMENVATTING 
Daar er tot nu toe geen studies beschreven zijn, waaruit duidelijke conclusies 
getrokken kunnen worden ten aanzien van het nut van natriumbeperking tijdens de 
zwangerschap werd een gezamelijk onderzoeksproject opgezet in meerdere 
ziekenhuizen in Nederland (Catharina Ziekenhuis Eindhoven, Academisch 
Ziekenhuis Nijmegen en Bosch Medicentrum 's-Hertogenbosch) ter evaluatie van het 
preventieve effect van een natriumbeperkt dieet op het ontstaan van 
zwangerschapshypertensie. Echter voordat aanbevelingen gedaan kunnen worden ten 
aanzien van de zoutinname tijdens de zwangerschap is het belangrijk een grondige 
kennis te hebben van mogelijke (patho)fysiologische consequenties van een 
verandering in de inname van zout voor moeder en kind. Tot nu toe zijn hierover nog 
maar weinig studies verschenen. Daarom werden in ieder deelnemend ziekenhuis ook 
verschillende mogelijke neveneffecten van het natriumbeperkte dieet tijdens de 
zwangerschap bestudeerd. In het Bosch Medicentrum te 's-Hertogenbosch werd in 
samenwerking met de vakgroep Humane Voeding van de Landbouwuniversiteit te 
Wageningen het gezamelijke studieprotocol op een zodanige wijze uitgebreid dat ook 
de effecten van het natriumbeperkte dieet op de maternale energie- en 
nutriènteninname, calciummetabolisme, zink- en magnesiumstatus, gewichtsloename 
en vetopslag onderzocht konden worden. Omdat er aanwijzingen zijn dat al deze 
variabelen gerelateerd zouden kunnen zijn aan de zwangerschapsuitkomst kan het 
natriumbeperkte dieet via effecten op deze variabelen gevolgen hebben voor de 
gezondheid van moeder en kind. In dit proefschrift zijn de resultaten van het 
onderzoek uitgevoerd in het Bosch Medicentrum beschreven. 
Vierennegentig nulliparae participeerden in deze longitudinale studie. Eenenveertig 
vrouwen gebruikten een natriumbeperkt dieet vanaf de 14e zwangerschapsweek tot 
aan de bevalling (interventie-groep; gemiddelde natriumuitscheiding via de urine 61 
mmol/24u) en 53 vrouwen continueerden hun ad libitum dieet (controle-groep; 
gemiddelde natriumuitscheiding via de urine 142 mmol/24u). Metingen werden in 
beide groepen verricht voor de aanvang van de interventie (13e zwangerschapsweek), 
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daarna ongeveer iedere 4 weken tot aan de bevalling en 1, 2 en 6 weken post partum. 
Er werd geen effect van hel natriumbeperkte dieet op het verloop van de bloeddruk 
en de incidentie van zwangerschapshypertensie gevonden (Hoofdstuk 2). De 
verminderde natriuminname ging gepaard met een significant verminderde inname 
van energie, eiwitten, koolhydraten, vetten, calcium, zink, magnesium, ijzer en 
cholesterol (Hoofdstuk 3). Door het gebruik van een natriumbeperkt dieet tijdens de 
zwangerschap ontstond er dus een verhoogd risico op een inadequate aanvoer van 
energie en nutriënten naar de moeder en het kind. Dit gold met name voor de 
verminderde inname van zink en ijzer, daar de inname van deze micronutriënten 
reeds in de controle-groep veel lager was dan de aanbevolen hoeveelheden voor 
zwangere vrouwen (respectievelijk 35% en 43% lager dan de aanbevolen 
hoeveelheden). Bij de vrouwen die een natriumbeperkt dieet gebruikten werd een 
significant verminderde calciumuitscheiding via de urine gevonden (Hoofdstuk 2). 
Een verminderde calciuminname veroorzaakt een verminderde calciumuitscheiding 
door de nieren via een verhoogde secretie van parathormoon. In deze studie werd 
echter geen verandering in circulerend parathormoon gevonden bij de vrouwen die 
een natriumbeperkt dieet gebruikten. Het lijkt dan ook waarschijnlijker dat de 
verminderde calciumuitscheiding via de urine een gevolg was van de verminderde 
natriumuitscheiding. AJ eerder werd een direkte en positieve relatie beschreven 
tussen de uitscheiding van natrium en calcium door de nieren. De verminderde 
inname en de afgenomen uitscheiding van calcium waren mogelijk compensatoir, 
waardoor er geen veranderingen gevonden werden in circulerend totaal calcium, 
geïoniseerd calcium en parathormoon bij de vrouwen die een natriumbeperkt dieet 
gebruikten tijdens de zwangerschap (Hoofdstuk 2). De significant verminderde 
inname van zink en magnesium door de vrouwen die een natriumbeperkt dieet 
gebruikten resulteerde niet in significante veranderingen in serum zink, plasma 
alkalische fosfatase of serum magnesium, waarschijnlijk als gevolg van homeostatische 
aanpassingen door de nieren (Hoofdstuk 4). Natriumbeperking tijdens de 
zwangerschap beïnvloedde de maternale zink- en magnesiumstatus dus niet. Bij de 
vrouwen die een natriumbeperkt dieet gebruikten werden verminderde toenames in 
gewicht (1.5 kg) en vet (0.9 kg) tijdens de zwangerschap gevonden, die echter niet 
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statistisch significant waren (Hoofdstuk 5). Als alleen de gegevens van de vrouwen die 
zich goed aan het dieet gehouden hadden (op basis van hun natriumuitscheiding via 
de urine tijdens de interventieperiode) geanalyseerd werden bleken de reducties in 
gewichts- en vettoename groter (respectievelijk 3.4 kg (p = 0.003) en 1.3 kg (p = 0.15)). 
Geconcludeerd werd dat een natriumbeperkt dieet tijdens de zwangerschap een 
verminderde maternale gewichtstoename veroorzaakt, waarschijnlijk als gevolg van 
een verminderde expansie van het extracellulaire vocht en gedeeltelijk door een 
vermindere vetopslag. Er werden geen effecten van het dieet op het geboortegewicht 
van het kind, placentagewicht of andere zwangerschapsuitkomstvanabelen (lengte en 
schedelomtrek kind, apgarscores, arteriële pH navelstrengbloed) gevonden 
(Hoofdstuk 5). 
In deze studie resulteerde het voorschrijven van een natriumbeperkt dieet tijdens de 
zwangerschap in een verminderde inname van energie en andere nutriënten. De 
zwangere vrouwen leken echter prima in staat tot aanpassing aan de verminderde 
inname, daar calcium-, zink- en magnesiumhomeostasis gehandhaafd bleef. Tevens 
werd er geen effect op het geboortegewicht van het kind gevonden. De resultaten van 
deze studie vormen derhalve geen reden om natriumbeperking bij gezonde 
Nederlandse zwangere vrouwen, die in een goede voedingstoestand verkeren, af te 
raden. Echter, door de afwezigheid van een positief effect van het natriumbeperkte 
dieet op de bloeddruk en de incidentie van zwangerschapshypertensie wordt het 
voorschrijven van zo'n dieet als preventieve maatregel tijdens de zwangerschap niet 
aanbevolen. Voor een definitieve conclusie ten aanzien van de aanbevelingen voor de 
inname van zout tijdens de zwangerschap zullen de resultaten van de gezamelijke 
studie en de resultaten van de andere participerende ziekenhuizen met betrekking tot 
de neveneffecten van het natriumbeperkte dieet afgewacht moeten worden. 
123 

DANKWOORD 
Het in dit proefschrift beschreven onderzoek werd uitgevoerd binnen de polikliniek 
gynaecologie van het Bosch Medicentrum (locatie Groot Ziekengasthuis) te 
's-Hertogenbosch, in zeer nauwe samenwerking met de vakgroep Humane Voeding 
van de Landbouwuniversiteit te Wageningen. Het proefschrift is tot stand gekomen 
dankzij' de medewerking van velen. Hierbij wil ik een ieder die op een of andere 
manier heeft bijgedragen heel hartelijk bedanken, in het bijzonder alle deelneemsters. 
Zonder jullie gemotiveerde en enthousiaste deelname was het onderzoek nooit 
mogelijk geweest. 
Een aantal personen wil ik met name noemen en bedanken: 
Joop van Raaij, zonder jouw intensieve begeleiding was het onderzoek waarschijnlijk 
in de prullemand verdwenen. Het is ongelovelijk hoeveel tijd en aandacht jij eraan 
besteed hebt. Je was steeds weer bereid om ieder onderdeel uitgebreid te bespreken, 
vragen te beantwoorden, problemen op te lossen en onzekerheden weg te nemen. 
Van jouw kennis, zowel inhoudelijk als t.a.v. het verrichten van wetenschappelijk 
onderzoek, die je op een hele prettige manier wist over te brengen, heb ik heel veel 
geleerd. Mijn dank is zeer groot. Professor Hautvast, uw belangstelling en 
enthousiasme voor het onderzoek waren zeer belangrijk voor mij. Ook uw kritische 
beoordelingen van de artikelen, waarvoor u ondanks uw druk bezette agenda steeds 
weer de tijd nam, heb ik zeer gewaardeerd. Herman Oosterbaan, met jouw valt 
uitstekend afspraken te maken. Zeer bedankt voor het verzorgen van de uitgebreide 
correspondentie met het Praeventiefonds, waardoor het onderzoek qua personeel, 
apparatuur en financiën uitstekend geregeld was. Ook al was ik niet altijd blij met al 
die blauwe strepen in de artikelen, het heeft zeker bijgedragen tot een betere 
kwaliteit. Dr. de Boer, bedankt voor uw bijdrage aan het onderzoek en voor uw 
gastvrijheid. Ook al was u in de latere jaren van het onderzoek wat minder betrokken 
bij de onderzoeksactiviteiten uw steun was duidelijk. Professor Eskes, bedankt voor 
125 
Z0U4MPI RKING lUDh-Nb/WANCFRSCHAP DANKWOORD 
uw bijdrage, met name tijdens de afrondingsfase van het onderzoek en voor uw 
trouwe aanwezigheid bij de besprekingen Leontien Visman, jouw aandeel aan het 
onderzoek was bijzonder groot. Dank je wel voor o.a. het nauwgezet verzamelen en 
verwerken van de voedselconsumptiegegevens. Bijna niemand beseft wat een heidens 
karwei dat is geweest. Jolanda Wijten, bedankt voor de zeer nauwkeurige data-invoer 
en andere secretariële werkzaamheden Leontien en Jolanda wil ik tevens bedanken 
voor de prettige samenwerking Lidwien van der Heijden, bedankt dat je altijd 
bereikbaar was voor vragen/problemen, m.n ten aanzien van het voedselconsumptie-
onderzoek en voor je kritische aantekeningen bij de artikelen Doktersassistenten en 
secretaresses, dank jullie wel dat er altijd iets te regelen viel, zodat o a de bezoeken 
van de deelneemsters soepel konden verlopen, en voor jullie belangstelling, steun en 
gezelschap. Noret Gerbrands, heel hartelijk bedankt voor je bereidheid om steeds 
weer bergen artikelen uit de kelder te halen of aan te vragen en natuurlijk voor de 
vele kopjes thee Personeel klinisch chemisch en hematologisch laboratorium, bedankt 
voor de bloedafnames en de ontelbare bloed- en unneanalyses. Klinisch chemicus 
J M Ramakers, u was het aanspreekpunt bij vragen/problemen t av de bloed- en 
unnebepalingen Dank u wel dat u steeds weer bereid was de ingewikkelde materie 
uit te leggen Ook de klinisch chemici, dr. H J H Kreutzer en A W Penmngs wil ik 
bedanken voor hun bijdrage De doctoraalstudenten Lara van Aalst, Toos Lemmens, 
Lucie Viet, Ingrid Slob, Roger van der Hammen, Emmy de Vries en Juliet Rijskamp, 
bedankt voor jullie bijdrage en de pret die we hadden Caroline Spaaij, dank je wel 
dat je me letterlijk en figuurlijk de weg wees binnen de Landbouwumveisiteit, voor 
het kritisch doornemen van het manuscript en de waardevolle opmerkingen Riekie 
Janssen, Marie Jansen en Gerda Theunissen, wil ik hartelijk bedanken voor de 
secretariële ondersteuning. Het personeel van de afdeling klinische fysica van het 
Groot Ziekengasthuis en Hannie van Oosten, bedankt voor de hulp geboden bij de 
gebruikte computerprogramma's en apparatuur. Verder wil ik bedanken voor hun 
bijdrage hoofd poliklinieken dhr van Swelm, de directiesecretaresses van het Groot 
Ziekengasthuis en het personeel van de tekenkamer van de Landbouwuniversiteit 
Tevens de gynaecologen van het Groot Ziekengasthuis voor het aandragen van de 
deelneemsters, de arts-assistenten gynaecologie voor hun steun en belangstelling en 
126 
ZOUTBEPORKING TIJDFNS ZWANGF-RSCHAP DANKWOORD 
het personeel van de afdeling verloskunde en gynaecologie voor de prettige 
samenwerking. Francine de Jong wil ik bedanken voor het ontwerpen van de omslag 
en het langdurig beschikbaar stellen van kostbare apparatuur. Familie en vrienden, 
bedankt voor jullie steun en begrip in moeilijke tijden. Menno, de ellende die een 
promotieonderzoek met zich meebrengt is niet te vergoelijken. Toch wil ik je 
bedanken dat je er wilde zijn en voor het samen delen van toekomstdromen, dat ze 
werkelijkheid mogen worden ! 
127 
CURRICULUM VITAE 
Gerneke van der Maten werd op 3 juni 1964 te Heerde geboren In 1982 behaalde zij 
haar VWO-diploma aan de Christelijke Scholengemeenschap de Heertganck te 
Heerde Zij begon haar studie geneeskunde aan de Rijksuniversiteit Limburg te 
Maastricht in september 1982 Op 9 januari 1989 werd het arts-examen behaald. Van 
1 maart tot 1 oktober 1989 was zij als arts-assistent gynaecologie/verloskunde 
werkzaam in het St Gregonus de Grote Ziekenhuis te Brunssum Op 1 oktober 1989 
trad zij in dienst als arts/onderzoeker bij de afdeling gynaecologie/verloskunde van 
het Bosch Medicentrum (lokatie Groot Ziekengasthuis) te VHertogenbosch Hier 
werd van 15 november 1989 tot 1 juli 1994 het onderzoek uitgevoerd dat in dit 
proefschrift beschreven is. Tijdens het onderzoek werd zeer intensief samengewerkt 
met de vakgroep Humane Voeding van de Landbouwuniversiteit te Wageningen 
128 
STELLINGEN 
behorende bij het proefschrift 
Low sodium diet in pregnancy: 
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1. Het gebruik van een natriumbeperkt dieet tijdens het 2e en 3e trimester van de 
zwangerschap heeft geen invloed op het verloop van de bloeddruk. 
(dit proefschrift) 
2. Het gebruik van een natriumbeperkt dieet tijdens de zwangerschap veroorzaakt 
tevens een verminderde inname van energie, eiwitten, koolhydraten, vetten, 
calcium, zink, magnesium, ijzer en cholesterol. 
(dit proefschrift) 
3. De Nederlandse zwangere vrouw is prima in staat tot aanpassing aan een (door 
het gebruik van een natriumbeperkt dieet veroorzaakte) verminderde inname 
van calcium, zink en magnesium. 
(dit proefschrift) 
4. Thans werkt de wetenschappelijke mens even hard als de vierde stand, de 
slavenstand, hij werkt, zijn studie is geen bezigheid meer maar een noodzaak, hij 
kijkt niet naar links en niet naar rechts en handelt al het werk en evenzo alle 
zwarigheden die het leven in petto heeft, met de verdeelde aandacht of met de 
weerzinwekkende behoefte aan ontspanning af, die de afgematte arbeider eigen 
is. 
(F. Nietzsche. Oneigentijdse beschouwingen) 
5. Over voorbije sores is het goed praten. 
(Jiddisch spreekwoord) 
6. Reisgedicht: 
Als ik mijn ogen toedoe, 
Ben ik in Honoloeloe. 
(J.A. Deelder) 
7. Tegenwoordig denken mensen recht te hebben op alles wat ze heel graag willen. 
(Cursus inleiding wijsgerige ethiek, Universiteit Utrecht, 1994) 
8. Als de laatste vis gevangen is, de laatste boom geveld en de laatste rivier 
vergiftigd, zul je erachter komen dat je geld niet kunt eten. 
(Indianenopperhoofd Seattle) 
9. Heb moed te denken. 



